Document:

EX-4.3

 Exhibit 4.3 

PRUDENTIAL PLC DEED OF INDEMNITY 
 NAME: ANNE
HELEN RICHARDS 
 Between 
  

	(1)	Prudential plc (registered number 01397169) whose registered office is at Laurence Pountney Hill, London EC4R 0HH (“Prudential”); and 

 

	(2)	Anne Helen Richards, Laurence Pountney Hill, London, EC4R 0HH (the “Beneficiary”) 

 Background

  

	(A)	The Beneficiary holds, or will from time to time hold, the position of: 

  

	 	(i)	director, officer, employee, trustee, representative or like position of any member of the Group; or 

  

	 	(ii)	director, officer, employee, trustee, governor, councillor, representative or like position in any external organisation at the request of any member of the Group (or as a result of being a director, officer, employee,
trustee or representative, or holding like position in respect of, any member of the Group). 

  

	(B)	Prudential has agreed to indemnify the Beneficiary and his Dependants against certain personal liabilities and expenses arising out of or in connection with such positions on the terms of this Deed. 

 

	(C)	Prudential will not, however, indemnify the Beneficiary and his Dependants if it is contrary to law. 

 Agreement

  

	1.	Indemnity 

 Subject to the following paragraphs of this Deed, Prudential undertakes to indemnify
each Beneficiary Family Member and hold each Beneficiary Family Member harmless against any and all losses, damages, costs, liabilities, demands, charges, penalties, fines, interest or expenses (including without limitation any and all losses,
costs, liabilities, charges or expenses properly and reasonably suffered or incurred (including advisory fees)) in investigating, responding to, preparing for or disputing any claim, action, demand, proceedings, investigation (whether formal or
informal), judgment or award, in each case whether or not successful, compromised or settled, which may be instituted, made, threatened or alleged against or otherwise involve any of the Beneficiary Family Members in any jurisdiction (each a
“Claim”) which the Beneficiary Family Members may suffer or incur in any jurisdiction (“Losses”) and which in any such case arise out of or in connection with the carrying out or performance, whether before (subject
to paragraph 17 below) or after the date of this Deed, by the Beneficiary of the Beneficiary’s duties as a director, officer, employee, trustee, representative or like position of any member of the Group or as a director, officer, employee,
trustee, governor, councillor, representative or like position in any external organisation where such position is held at the request of any member of the Group or as a result of being a director, officer, employee, trustee or representative, or
holding like position in respect of, any member of the Group. 

	2.	Indemnity to take effect subject to law and regulation 

 The indemnity contained in paragraph 1
shall not apply to the extent that it would be void by virtue of, or contravenes, the Companies Act 2006 or any other applicable law or regulation (including without limitation listing rules). 

 

	3.	Proceedings for which indemnity cannot be claimed 

 Subject to paragraph 5, the indemnity contained
in paragraph 1 shall not extend to any liability incurred by the Beneficiary, (i) to any member of the Group, (ii) to pay a fine imposed in criminal proceedings, (iii) to pay a sum payable to a regulatory authority by way of a penalty
in respect of non-compliance with any requirement of a regulatory nature (however arising), (iv) in defending any criminal proceedings in which the Beneficiary is convicted, (v) as a result of, or in
connection with any act or omission by the Beneficiary which is determined by any relevant court, tribunal or other legal or regulatory authority, or otherwise judicially, determined, to constitute fraud, dishonesty, bad faith, wilful default or
criminal act on the part of the Beneficiary, (vi) in defending civil proceedings brought by any member of the Group in which judgment is given against the Beneficiary or (vii) in connection with any application under the Application for
Relief Sections in which the Court refuses to grant relief to the Beneficiary. 
  

	4.	Loss of earnings and of other employment benefits 

 The indemnity contained in paragraph 1 shall not
apply in respect of any loss of earnings or of any other employment benefit, including but not limited to rights to bonus or other monetary incentives, share options or other share-based incentives or pension or other retirement benefits, which any
Beneficiary Family Member may suffer as a result of any period of disqualification imposed by any relevant court, tribunal or other legal or regulatory authority. 
  

	5.	Advances in respect of proceedings 

 Where any Beneficiary Family Member properly and reasonably
suffers or incurs losses, costs, liabilities, charges or expenses (including without limitation advisory fees) in investigating, responding to, preparing for or disputing any Claim, the Beneficiary shall be entitled to claim indemnity under
paragraph 1 (for himself and/or on behalf of any Beneficiary Family Member) forthwith after the same becomes due and payable by the Beneficiary Family Member, provided that if such Claim: 

 

	 	(a)	relates to a criminal offence in relation to which the Beneficiary is convicted; 

  

	 	(b)	relates to civil proceedings brought by any member of the Group in which judgment is given against the Beneficiary; 

  

	 	(c)	relate to any matters in respect of which any relevant court, tribunal or other legal or regulatory authority determines that any act or omission by the Beneficiary constitutes fraud, dishonesty, bad faith or wilful
default on the part of the Beneficiary; or 

  

	 	(d)	relates to any application under the Application for Relief Sections in which the Court refuses to grant the Beneficiary relief, 

Prudential shall be entitled to refuse to provide indemnification (or, as the case may be, any further indemnification) pursuant to the indemnity
contained in paragraph 1 and where Prudential has already paid amounts to the Beneficiary pursuant to the indemnity contained in paragraph 1, such amounts shall be reimbursed to Prudential by the Beneficiary not later than (i) in the event of
the Beneficiary being convicted, the date on which such conviction has become final, (ii) in the event of judgment being given against the Beneficiary, the date on which such judgment has become final, (iii) in the event of any relevant
court, tribunal or other legal or regulatory authority determining that any act or omission by the Beneficiary constitutes fraud, dishonesty, bad faith or wilful default on the part of the Beneficiary, the date of such determination or (iv) in
the event of the court refusing to grant the Beneficiary relief on the application, the date on which such refusal for relief has become final. 

  
 2 

	6.	Termination and survival 

 The provisions of this Deed shall survive: 

 

	 	(a)	the Beneficiary moving to another role within the Group which does not have the benefit of an indemnity equivalent to the indemnity contained in paragraph 1; and 

 

	 	(b)	the termination of any or all appointments of the Beneficiary within the Group, excluding (i) termination by the Beneficiary in fundamental breach of the terms of his appointment with any member of the Group; or
(ii) termination by Prudential by reason of the Beneficiary’s fraud or wilful and serious neglect of his duties. In the event of a dispute relating to this paragraph 6(b), Prudential shall provide indemnification (or, as the case may be,
further indemnification) pursuant to the indemnity contained in paragraph 1 until a competent court, tribunal or other legal or regulatory authority, from which there is no right of appeal, determines that any act or omission by the Beneficiary
constitutes a fundamental breach of the terms of his appointment with any member of the Group, fraud or wilful and serious neglect by the Beneficiary of his duties. 

 

	7.	Notification of Prudential 

 The Beneficiary shall notify Prudential in writing promptly upon
becoming aware of any matter for which indemnity may be sought under paragraph 1, providing to Prudential all such information as the Beneficiary has of the circumstances of the relevant matter, and shall thereafter provide Prudential with all such
information as Prudential may reasonably require about developments in relation to such matter. The Beneficiary acknowledges that Prudential may provide such information to its insurers and advisers and to, any other member of the Group and agrees
to respond promptly to all reasonable requests from Prudential in relation to any matter relating to the indemnity contained in paragraph 1. 
  

	8.	Conduct of Claims 

  

	 	(a)	The Beneficiary shall, subject to paragraph 8(b), have conduct of the defence and settlement of any Claim, but Prudential shall have the right (but not the obligation) to associate itself with such Claim provided the
Beneficiary consents to this. Prudential shall not be required or, without the consent of the Beneficiary (such consent not to be unreasonably withheld or delayed), permitted to assume the conduct of the Claim made against the Beneficiary.

  

	 	(b)	The Beneficiary shall conduct all Claims diligently and competently using the legal and other representatives mutually acceptable to the Beneficiary and Prudential. The Beneficiary shall keep Prudential reasonably
informed of the progress of any Claim and recognises the right of Prudential to provide at its discretion input into the conduct of any Claim. The Beneficiary shall not settle or compromise any Claim without Prudential’s consent (such consent
not to be unreasonably withheld or delayed). 

  

	9.	Recovery against other persons 

 If Prudential pays any amount in respect of any Losses and any
Beneficiary Family Member is, or subsequently becomes, entitled to recover from any other person any amount in respect of such Losses (including without limitation by way of tax credit, allowance, repayment or relief), then, subject to there being
no reasonable prospect of any Beneficiary Family Member being prejudiced and to Prudential agreeing to indemnify the Beneficiary Family Members against all reasonable costs and expenses which might be incurred, Prudential may either: 

  
 3 

	 	(a)	request that the Beneficiary take (or procure that any Dependant take) all reasonable steps to enforce such recovery. If Prudential so elects then the Beneficiary must so act and must procure that all and any amounts
recovered, less all reasonable costs, charges and expenses incurred and not recovered by any Beneficiary Family Member in making such recovery, will be applied in promptly repaying to Prudential the amount paid by Prudential in respect of the
Losses; or 

  

	 	(b)	exercise its right to be subrogated to the extent of such payment to any or all the Beneficiary Family Members’ rights of recovery against third parties in respect of the payment. If Prudential so elects then the
Beneficiary shall (or. shall procure that the Dependants shall), promptly on request from Prudential, execute all papers reasonably required and shall do everything necessary to enable Prudential to bring, maintain and conclude an action
effectively, either in the name of all or any Beneficiary Family Members or in its own name, at Prudential’s discretion. 

  

	10.	Recovery under other indemnities and insurance 

  

	 	(a)	Subject to paragraph 10(c), the Beneficiary agrees to take, and to procure that the Dependants take, all reasonable steps to claim and recover under any other indemnity or insurance policy before he makes a claim under
the indemnity contained in paragraph 1. The indemnity contained in paragraph 1 operates only in excess of any right to indemnity or insurance which any Beneficiary Family Member may have (irrespective of any wording to the contrary in any indemnity
or insurance policy concerned), and no person other than the Beneficiary shall have the right to pursue any claim against Prudential under the indemnity contained in paragraph 1 (or to seek contribution from Prudential) whether in his own name or
that of any Beneficiary Family Member. 

  

	 	(b)	Provided that the Beneficiary complies with paragraph 10(a), Prudential will advance to the Beneficiary the funds necessary to make a payment in respect of any Losses pending receipt by the Beneficiary Family Member of
the amounts due under any other indemnity and/or insurance policy in excess of which the indemnity contained in paragraph 1 operates. Any such advance will not operate to extinguish, erode or otherwise limit in any way whatsoever the Beneficiary
Family Members’ entitlement under the other indemnity and/or insurance policy and the Beneficiary shall remit (or shall procure that there shall be remitted) to Prudential all and any payments and/or benefits received pursuant thereto
subsequent to the date of the advance required to repay the advance. 

  

	 	(c)	The obligation to take all reasonable steps to claim and recover under any other indemnity or insurance policy set out in paragraph 10(a) shall not operate in respect of any policy of executives’ and officers’
liability insurance for which any member of the Group is the named policyholder and which requires that any Beneficiary Family Member be indemnified by a member of the Group prior to any claim being brought under that policy. 

 

	11.	Deductions required to be made by Prudential or a Beneficiary Family Member 

  

	 	(a)	All amounts payable by Prudential to, or on behalf of, any Beneficiary Family Member under this Deed of indemnity will be paid without any deductions unless they are required by law. If any deductions are required by
law, Prudential will pay to, or on behalf of, the Beneficiary Family Member an amount which will, after any deduction has been made, result in the Beneficiary Family Member receiving the same amount as the Beneficiary Family Member would have been
entitled to receive in the absence of any requirement to make a deduction. 

  

	 	(b)	If any amount payable by Prudential under this Deed of indemnity is subject to tax in the hands of the Beneficiary Family Member in any jurisdiction, the amount payable will be increased so that the net amount received
by the Beneficiary after taking that tax into account is equal to the full amount which would have been received by the Beneficiary Family Member if that tax had not been payable. 

  
 4 

	 	(c)	To the extent that any Beneficiary Family Member obtains any tax credit, allowance, repayment or relief as a result of Prudential paying any increased amount under this paragraph 11, the Beneficiary shall repay, or
procure that the Dependant repays, to Prudential the amount necessary to reflect the principle that, after tax, the Beneficiary Family Member is to be put in the same position as if the deduction or charge to tax had not been required or incurred in
the first place. 

  

	12.	No double recovery 

 Notwithstanding the provisions of this Deed, the Beneficiary shall have the
benefit of any indemnity, insurance, agreement, undertaking or commitment entered into with, or on his behalf by, any member of the Group whether before (subject to paragraph 17 below) or after the date of this Deed, provided that he shall not be
entitled to recover more than once under this indemnity and any other indemnity, insurance, agreement, undertaking or commitment in respect of any Losses. 
  

	13.	Interpretation 

 In this Deed: 

 

	 	(a)	“Application for Relief Sections” means, 

 when such provisions have come into force: 

 

	 	(i)	section 661(3) or (4) of the Companies Act 2006 (acquisition of shares by innocent nominee); or 

  

	 	(ii)	section 1157 of the Companies Act 2006 (general power to grant relief in case of honest and reasonable conduct); 

  

	 	(b)	“Beneficiary Family Members” mean the Beneficiary and the Dependants; 

  

	 	(c)	“Claim” has the meaning ascribed to it in paragraph 1; 

  

	 	(d)	“Companies Act 2006” means the Companies Act 2006 as amended, modified, re enacted or replaced from time to time; 

  

	 	(e)	“Deed” means this deed; 

  

	 	(f)	“Dependant” means: 

  

	 	(i)	the Beneficiary’s spouse or civil partner; 

  

	 	(ii)	any other person (whether of a different sex or the same sex) with whom the Beneficiary lives as partner in an enduring family relationship other than the Beneficiary’s grandparent or grandchild, sister, brother,
aunt or uncle, or nephew or niece; 

  

	 	(iii)	the Beneficiary’s children or step-children; 

  

	 	(iv)	any children or step-children of a person within paragraph 13(g)(ii) (and who are not children or step-children of the Beneficiary) who live with the Beneficiary and have not attained the age of 18; and

  

	 	(v)	the Beneficiary’s parents; 

  
 5 

	 	(h)	“director” shall include without limitation shadow director; 

  

	 	(i)	“Existing Indemnity” means any previous agreement between the Beneficiary and Prudential relating to the subject matter of this Deed, including any indemnity previously given by Prudential to any
Beneficiary Family Member in respect of any of the matters covered by this Deed; 

  

	 	(j)	“Group” means Prudential or any subsidiary or holding company of Prudential or any subsidiary of a holding company of Prudential; 

 

	 	(k)	“Losses” have the meaning ascribed to them in paragraph 1; 

  

	 	(l)	“holding company” and “subsidiary” have the meanings ascribed to them in the Companies Act 2006; 

  

	 	(m)	a reference to a “conviction”, “judgment”, “determination” or “refusal of relief” is a reference to one that has become final. For these purposes, a
conviction, judgment, determination or refusal of relief becomes final: 

  

	 	(i)	if not appealed against, at the end of the period for bringing an appeal; or 

  

	 	(ii)	if appealed against, at the time when the appeal (or any further appeal) is disposed of. 

  An appeal is disposed of: 
  

	 	(iii)	if it is determined and the period for bringing any further appeal has ended; or 

  

	 	(iv)	if it is abandoned or otherwise ceases to have effect; and 

  

	 	(n)	any reference to the masculine shall as appropriate be a reference to the feminine. 

  

	14.	Claims and enforcement 

  

	 	(a)	Prudential shall be entitled to take steps in relation to the provisions of this Deed. In taking any such step, Prudential may act for itself and/or on behalf of any of all other members of the Group. 

 

	 	(b)	The Beneficiary and his personal representatives and estate shall be entitled to make a claim, and take any other steps, in relation to the provisions of this Deed. In taking any such step, the Beneficiary may act for
himself and/or on behalf of any or all of the Dependants. 

  

	 	(c)	Subject to paragraphs 14(a) and (b), any person other than Prudential and the Beneficiary may not enforce any of the provisions of this Deed under the Contracts (Rights of Third Parties) Act 1999. 

 

	15.	Miscellaneous 

  

	 	(a)	The Beneficiary may not assign or otherwise transfer any rights or obligations set out in this Deed. 

  

	 	(b)	Any failure by Prudential or the Beneficiary to exercise any right, power or privilege available under this Deed is not a waiver for the purposes of this Deed nor will any single or partial exercise thereof preclude any
further exercise of any right, power or privilege. 

  

	 	(c)	The provisions of this Deed may only be amended in writing signed by or on behalf of Prudential and the Beneficiary. 

  
 6 

	 	(d)	If any provision of this Deed is held to be illegal, invalid or unenforceable in whole or in part, the remaining provisions shall continue to be valid. 

 

	 	(e)	Prudential and the Beneficiary acknowledge that any contract, agreement, commitment or undertaking in respect of the Beneficiary’s role as a director, officer, employee, trustee or representative of Prudential
incorporates, and accordingly is made on and subject to, the provisions of the Memorandum and Articles of Association of Prudential. 

  

	16.	Employment terms and conditions 

 If the Beneficiary is also an employee of any member of the Group,
the Beneficiary acknowledges that this Deed shall be deemed to be incorporated into the employment contract between the Beneficiary and the relevant member of the Group as supplementary terms thereto. 

 

	17.	Effective date 

 The indemnity contained in paragraph 1 shall apply in respect of any Claims or
losses made or incurred on or after the date of commencement of the Beneficiary’s position as director, officer, employee, trustee, representative or like position of any member of the Group, or as director, officer, employee, trustee,
governor, councillor, representative or like position in any external organisation at the request of any member of the Group (or as a result of being a director, officer, employee, trustee or representative, or holding like position in respect of,
any member of the Group). 
  

	18.	Governing law 

 The provisions set out in this Deed are governed by and must be interpreted in
accordance with English law. 
  

	19.	Arbitration 

  

	 	(a)	Any dispute, controversy or claim arising out of or in connection with this Deed shall be referred to and finally resolved by arbitration under the Rules or Arbitration of the International Chamber of Commerce
(“ICC Rules”) by three arbitrators appointed in accordance with the ICC Rules. 

  

	 	(b)	The seat of the arbitration shall be London and the language of the arbitration (in which each member of the tribunal shall be fluent) shall be English. 

This document has been executed as a deed and is to be treated as delivered on the later of (a) being executed and dated by Prudential and (b) being
signed and dated by the Beneficiary. 
 Executed and delivered as a deed     ) 

by affixing the common seal of           ) 

Prudential plc in the presence of:    ) 
 Paul Manduca 

/s/ Paul Manduca 
 Date: 8 June 2016 

  
 7 

 Acknowledged and agreed: 
  

					
	Signed and delivered as a deed	 	)	  	
	By Anne Helen Richards	 	)	  	/s/ Anne Richards (Signature)
	in the presence of:	 	)	  	 16 June 2016 (Date)

		 		  	

 Witness signature: /s/ Sally Anne Harrison 
 Witness
name:       Sally Anne Harrison 
 Witness address:   5 Laurence Pountney Hill, London, EC4R 0HH 

  
 8EX-4.6

 Exhibit 4.6 

13 February 2014 
 Dear Howard 

PRUDENTIAL PLC - LETTER OF APPOINTMENT 
 This letter supersedes your previous
letter of appointment dated 15 October 2010. The Board of Prudential plc (the ‘Company’) appointed you as Non-executive Director with effect from 15 October 2010. I am now writing to set
out the revised terms of your appointment. It is agreed that this is a contract for services subject to the Company’s Articles of Association as amended from time to time and does not constitute a contract of employment. 

Appointment 
 Your appointment was subject to election by shareholders at the
AGM in 2011 and to receipt of all necessary legal and regulatory approvals. Continuation of your appointment will be contingent on satisfactory performance, re-election at forthcoming AGMs and any statutory
provisions relating to the removal of directors. Non-executive Directors are appointed on the understanding that they serve an initial term of three years and, subject to review by the Nomination Committee, a
second term of three years, both subject to annual election at the AGM. After six years of service, Non-executive Directors may be appointed for a further year, up to a maximum of three years, subject to an
annual review by the Nomination Committee. Good governance does not support the practice of serving longer than nine years on the Board as a Non-executive Director. 

If you are not confirmed or re-elected as a director by shareholders, or you are retired from office under the Company’s
Articles of Association, your appointment shall terminate automatically with immediate effect. 
 Participation in Committees 

Non-executive members of the Board are invited to serve on Committees of the Board, as determined by the Board from time to time.
The principal Committees are Audit, Risk, Remuneration and Nomination. The Schedule to this letter, as amended from time to time, lists the Committees of which you are a member. 

  
 1 

 Role 
 Non-executive Directors have the same general legal responsibilities to the Company as any other Director. The Board as a whole is collectively responsible for the success of the Company. The Board: 

 

	•	 	Provides entrepreneurial leadership of the Company within a framework of prudent and effective controls which enable risk to be assessed and managed; 

 

	•	 	Sets the Company’s strategic aims, ensures that the necessary financial, human and other resources are in place for the Company to meet its objectives, and reviews management performance; and 

 

	•	 	Sets the Company’s values and standards and ensures that its obligations to its shareholders and others are understood and met. 

Directors of any company must take decisions objectively in the interests of that company. As a director, you owe a fiduciary duty to the Company, which includes an
obligation not to do anything that might bring it into disrepute. A summary of responsibilities of Directors as applicable to the Company under current legislation will be provided to you. 

In addition to these general requirements of all Directors, the role of the Non-executive Director has the following key
elements: 
  

	 	•	 	Strategy. Non-executive Directors should constructively challenge and help develop proposals on strategy. 

 

	 	•	 	Performance. Non-executive Directors should scrutinise the performance of management in meeting agreed goals and objectives and monitor the reporting of performance. This
is achieved both at the Board and on a more individual level through the Remuneration Committee. 

  

	 	•	 	Risk. Non-executive Directors should satisfy themselves of the integrity of financial information and that financial controls and systems of risk management are robust and
defensible. This is achieved by escalating key issues to the Board either directly or via the Audit Committee. The Group Risk Committee also has an important role in this context. 

 

	 	•	 	People. Non-executive Directors have a prime role in appointing, and where necessary removing, Executive Directors and in succession planning. In addition, they are
responsible for determining appropriate levels of remuneration for Executive Directors. This business is mainly conducted via the Nomination and Remuneration Committees. Non-executive Directors also have a
prime role in upholding high standards of integrity and probity and in supporting the other directors in instilling the appropriate culture, values and behaviours in the boardroom and beyond. 

In this role, you will be a PRA Approved Person, holding a Non-executive Director controlled function (CF2) in respect of The
Prudential Assurance Company Limited (“PAC”). As an Approved Person, you must: 
  

	 	•	 	comply with the Statements of Principle and Code of Practice for Approved Persons (“APER”) set out in the APER section of the PRA Handbook; and 

  
 2 

	 	•	 	meet on an ongoing basis the fit and proper person test for Approved Persons (which covers honesty, integrity and reputation; competence and capability; and financial soundness). 

Group Compliance has provided you with guidance on the obligations of Approved Persons and how these apply to your role as a Controlled Function holder in respect of
PAC. 
 Time Commitment and fees 
 Time commitment will depend on the
Committees on which you serve and may change over time, depending on the issues faced by the business and your time in the role. The Schedule to this letter provides the current time expectations for Board and Committee membership. The Schedule is
reviewed on an annual basis and may be amended from time to time by the Company. 
 Whilst we acknowledge that you have other commitments which may mean you will not
be able to attend all meetings of the Board and relevant Committees, you have confirmed by accepting this appointment that you are able to allocate sufficient time to the Company’s affairs to meet the demands of the role. You must discuss any
additional commitments that might impact on the time you are able to devote to your role as a Non-executive Director of the Company with me prior to accepting. 

Non-executive Directors’ fees are subject to annual review by the Board, and will be in accordance with the policy approved
by shareholders from time to time, as required under the Companies Act 2006 (the “Approved Policy”). Fees accrue on a daily basis and are payable quarterly in arrears. The fees currently payable for Board membership and the additional fees
payable for other Committee memberships are set out in the Schedule to this letter, as amended from time to time. All fees are payable net of any tax and National Insurance contributions, where the Company is required to deduct these. 

As a Non-executive Director you are not entitled to participate in any of the Group’s executive remuneration programmes or
pension arrangements. 
 Directors are entitled to claim for business related expenses properly incurred by them in connection with their attendance at meetings of the
Board or Committees of the Board, general meetings or separate meetings of the holders of any class of shares or of debentures of the Company or otherwise in connection with the discharge of their duties. Documentary evidence of expenses incurred
should be submitted to my office for approval. 
 Shareholding, dealing and compliance 

The 2,500 Prudential qualification shares you purchased within your first year of appointment must be retained during the tenure of your office. 

The Board has also set a shareholding guideline for Non-executive Directors equivalent in value to the basic annual fee. This
shareholding should be acquired within a three-year period of the appointment becoming effective, or from the date of the introduction of the policy if earlier. 

  
 3 

 During your term in office you are subject to Prudential’s Share Dealing Rules, full particulars of which can be found
in the Board Reading Room on your iPad. The rules incorporate all relevant obligations arising from the Company’s listing in HK and the UK, as well as other relevant legislation. These are updated as required to reflect changes in
legislation and regulations, and will provide you with the necessary guidance on the steps you need to take and other considerations relating to share dealings. 
 If
you have any questions on this please consult with Group Secretariat. 
 Conflicts of interests, independence and disclosure obligations 

It is accepted and acknowledged that you have business interests other than those of the Company and we have discussed these and agreed that no conflicts of interest
currently exist (other than those authorised by the Board as part of the appointment process). In the event that you become aware of any future potential conflicts of interest, please disclose these to me and the Company Secretary as soon as
apparent and also prior to accepting appointments. In particular we would not wish our Directors to serve on the Boards of financial services competitors. 
 The Board
of the Company has determined that you are independent according to the provisions of the UK Corporate Governance Code and the Hong Kong Listing Rules, supported by your declaration of independence, and you will be identified as such in the
annual report and other documentation. If you are a member of the Audit Committee, you have also confirmed your independence in respect of the Securities and Exchange Act of 1934 as it applies to members of an audit committee of a Foreign Private
Issuer. If circumstances change, and you believe that your independence may be in doubt, you should discuss this with me as soon as possible. 
 The Company has an
obligation to notify details of other directorships held by its directors during the past five years to various regulators on an annual basis, together with non-statutory offices. Any changes in your external
appointments, including non-statutory offices, should be notified to the Company Secretary on an ongoing basis. In particular, any changes in your directorships of other quoted companies worldwide need to be
notified promptly, preferably the next business day, as the Company is required to announce this to various stock exchanges. 
 Wrongdoing 

You will immediately report to the Board your own wrongdoing or the wrongdoing or proposed wrongdoing of any employee or Director of which you become aware. 

  
 4 

 Termination of appointment 
 The
appointment may be terminated by and at the discretion of either party upon six months’ written notice. On termination of your appointment you shall resign from your office as director of the Company and of any offices you hold in any of the
Company’s group companies. Upon termination you will not be entitled to any compensation, other than accrued pro-rata fees, and you shall also cease to be a member of any Committee of the Board. All
records, documents, accounts, letters and papers of every description (including in particular Board and Committee agendas, minutes and papers) within your possession or control relating to the affairs and business of the Group are and will remain
the property of the Company, and shall be returned to the Company forthwith on termination. 
 Notwithstanding the above, your appointment may be terminated with
immediate effect if you: 
  

	(a)	commit a material breach of your obligations under this letter; or 

  

	(b)	commit any serious or repeated breach or non-observance of your obligations to the Company (which include an obligation not to breach your duties to the Company, whether
statutory, fiduciary or common-law); or 

  

	(c)	are guilty of any fraud or dishonesty or acted in a manner which, in the opinion of the Company acting reasonably, brings or is likely to bring you or the Company into disrepute or is materially adverse to the interests
of the Company; or 

  

	(d)	are convicted of any arrestable criminal offence other than an offence under road traffic legislation in the UK or elsewhere for which a fine or non-custodial penalty is imposed;
or 

  

	(e)	are declared bankrupt or have made an arrangement with or for the benefit of your creditors; or 

  

	(f)	are disqualified from acting as a director; 

  

	(g)	cease to hold PRA Approved Person status ; or 

  

	(h)	do not comply with the Group Anti-Bribery and Corruption Policy. 

 Confidentiality 

During your appointment you will have access to confidential information regarding the business and financial affairs of the Company and those of its subsidiaries,
undertakings and affiliates. You must not, either during your appointment or afterwards, disclose to anyone or otherwise make use of this confidential information, except in the proper performance of your duties or as may be required by law or by
any competent regulatory body. This does not apply, however, to any information already in the public domain. 

  
 5 

 Your attention is also drawn to the requirements under both legislation and regulation as to the disclosure of price
sensitive information. Consequently you should avoid making any statements that might risk a breach of these requirements without prior clearance from me or the Company Secretary. 

Data Protection 
 By signing this letter, you consent to the Company holding and
processing information about you for legal, personnel, administrative and management purposes and in particular to the processing of any sensitive personal data (as defined in the Data Protection Act 1998) including, as appropriate: 

 

	(a)	your racial or ethnic origin or religious or similar beliefs in order to monitor compliance with equal opportunities legislation; or 

 

	(b)	information relating to any criminal proceedings in which you have been involved for insurance purposes and in order to comply with legal requirements and obligations to third parties. 

You consent to the Company making such information available to any of its group companies, those who provide products or services to the Company (such as advisers and
payroll administrators), regulatory authorities, potential or future employers, governmental or quasi-governmental organisations and potential purchasers of the Company. 

You also consent to the transfer of such information to the Company’s business contacts outside the European Economic Area in order to further its business
interests. 
 Induction 
 Following your appointment, the Company provided an
induction programme which included meetings with senior management and the Company’s auditor and focussed on areas of specific interest to you. As part of your induction and during your term in office you received briefings on your duties as a
director generally and as a director of a company listed in the UK and HK. You also subsequently received a briefing on your obligations as a PRA Approved Person. 

Board evaluation 
 The performance of individual Directors and the whole Board
and its Committees is evaluated annually. If, in the interim, there are any matters which cause you concern about your role you should discuss them with me as soon as is appropriate. 

  
 6 

 Professional development 
 As a
Director you are invited to appropriate educational and/or professional development programmes from time to time. The Company Secretary will consult each director annually to ascertain their specific professional development needs. 

Directors’ and officers’ protection 
 The Company has directors’
and officers’ liability insurance and it is intended to maintain such cover for the full term of your appointment. A brief summary of the cover can be found in Prudential’s Guidance Notes for Directors, which is updated on a regular basis.

 The Company has also provided you with indemnity cover for directors’ and officers’ liability within the limitations imposed by law. In addition, the
Company will provide you with a limited indemnity for certain personal liabilities you may suffer in the course of your appointment, subject again to applicable statutory and other limitations, pursuant to the Company’s constitutional documents
or otherwise. 
 The Board has also resolved to have a discretionary payments policy (subject to regular review), the existence of which Directors (executive and non-executive) and certain employees or members of the Prudential Group may rely on, to protect them from personal liability arising out of the bona fide performance of their duties on behalf of the Group. 

Independent professional advice 
 Occasions may arise when you consider that you
need professional advice in the furtherance of your duties as a Director, and it may be appropriate for you to seek advice from independent advisers at the Company’s expense. This would normally be arranged through the Company Secretary. The
Company will reimburse the full cost of expenditure incurred in accordance with the policy. Details of the agreed procedure under which Directors may obtain such independent advice can be found in the Prudential Guidance Notes for Directors. 

Governing law and jurisdiction 
 This letter and any non-contractual obligations arising out of or in connection with it shall be governed by English law. The English courts have exclusive jurisdiction to settle any dispute arising in respect of it. 

Yours sincerely 
 /s/ Paul Manduca 

Paul Manduca 
 Chairman 

Prudential plc 

  
 7 

 Acknowledgement: 
  

	1.	By signing this letter, I agree to its terms. 

  

	2.	I acknowledge that this appointment letter does not constitute a contract of employment. 

  

	3.	I confirm that by having accepted this appointment, I am able to allocate sufficient time to meet the demands of the role. 

Signed: /s/ Howard Davies 
 Dated: February 2014 

  
 8 

 Sir Howard Davies 

Schedule 1 – Committee memberships as at 1 July 2016 
  

	 	•	 	Risk Committee (Chairman) 

  

	 	•	 	Audit Committee 

  

	 	•	 	Nomination Committee 

 Schedule 2 – time commitment and fees as at 1 July 2016 

 

									
	 	  	 	  	Number of
regular
scheduled
meetings	  	Approximate
time
commitment	  	 Fees per
annum

	 Board
	  		  	8	  	31 days	  	£95,000
	 Audit Committee
	  	Chairman Member	  	5	  	22.5-27.5 days
 15 days
	  	£75,000 £27,500
	 Risk Committee
	  	Chairman Member	  	5	  	19-24 days
 7.5 days
	  	£75,000 £27,500
	 Remuneration Committee
	  	Chairman Member	  	4	  	18-23 days
 5 days
	  	£60,000 £27,500
	 Nomination Committee
	  	Member	  	2	  	4 days	  	£10,000
	 Senior Independent Director
	  		  		  	10-25 days	  	£50,000

 Note: 
 In addition to the regular scheduled
meetings, the Committees may hold additional shorter meetings as relevant to discuss, for example, periodic financial reports, succession planning and other issues as they arise. 

  
 9 

 Exhibit 4.6 

13 February 2014 
 Dear Ann, 

PRUDENTIAL PLC - LETTER OF APPOINTMENT 
 This letter supersedes your previous
letter of appointment dated 2 August 2007. The Board of Prudential plc (the ‘Company’) appointed you as Non-executive Director with effect from 2 August 2007. I am now writing to set out the revised terms of your appointment. It
is agreed that this is a contract for services subject to the Company’s Articles of Association as amended from time to time and does not constitute a contract of employment. 

Appointment 
 Your appointment was subject to election by shareholders at the
AGM in 2008 and to receipt of all necessary legal and regulatory approvals. Continuation of your appointment will be contingent on satisfactory performance, re-election at forthcoming AGMs and any statutory provisions relating to the removal of
directors. Non-executive Directors are appointed on the understanding that they serve an initial term of three years and, subject to review by the Nomination Committee, a second term of three years, both subject to annual election at the AGM. After
six years of service, Non-executive Directors may be appointed for a further year, up to a maximum of three years, subject to an annual review by the Nomination Committee. Good governance does not support the practice of serving longer than nine
years on the Board as a Non-executive Director. 
 If you are not confirmed or re-elected as a director by shareholders, or you are retired from office under the
Company’s Articles of Association, your appointment shall terminate automatically with immediate effect. 
 Participation in Committees 

Non-executive members of the Board are invited to serve on Committees of the Board, as determined by the Board from time to time. The principal Committees are Audit,
Risk, Remuneration and Nomination. The Schedule to this letter, as amended from time to time, lists the Committees of which you are a member. 
 Role 

Non-executive Directors have the same general legal responsibilities to the Company as any other Director. The Board as a whole is collectively responsible for the
success of the Company. The Board: 

  
 10 

	•	 	Provides entrepreneurial leadership of the Company within a framework of prudent and effective controls which enable risk to be assessed and managed; 

 

	•	 	Sets the Company’s strategic aims, ensures that the necessary financial, human and other resources are in place for the Company to meet its objectives, and reviews management performance; and 

 

	•	 	Sets the Company’s values and standards and ensures that its obligations to its shareholders and others are understood and met. 

Directors of any company must take decisions objectively in the interests of that company. As a director, you owe a fiduciary duty to the Company, which includes an
obligation not to do anything that might bring it into disrepute. A summary of responsibilities of Directors as applicable to the Company under current legislation will be provided to you. 

In addition to these general requirements of all Directors, the role of the Non-executive Director has the following key elements: 

 

	 	•	 	Strategy. Non-executive Directors should constructively challenge and help develop proposals on strategy. 

  

	 	•	 	Performance. Non-executive Directors should scrutinise the performance of management in meeting agreed goals and objectives and monitor the reporting of performance. This is achieved both at the Board and on a
more individual level through the Remuneration Committee. 

  

	 	•	 	Risk. Non-executive Directors should satisfy themselves of the integrity of financial information and that financial controls and systems of risk management are robust and defensible. This is achieved by
escalating key issues to the Board either directly or via the Audit Committee. The Group Risk Committee also has an important role in this context. 

  

	 	•	 	People. Non-executive Directors have a prime role in appointing, and where necessary removing, Executive Directors and in succession planning. In addition, they are responsible for determining appropriate levels
of remuneration for Executive Directors. This business is mainly conducted via the Nomination and Remuneration Committees. Non-executive Directors also have a prime role in upholding high standards of integrity and probity and in supporting the
other directors in instilling the appropriate culture, values and behaviours in the boardroom and beyond. 

 In this role, you will be a PRA Approved
Person, holding a Non-executive Director controlled function (CF2) in respect of The Prudential Assurance Company Limited (“PAC”). As an Approved Person, you must: 
  

	 	•	 	comply with the Statements of Principle and Code of Practice for Approved Persons (“APER”) set out in the APER section of the PRA Handbook; and 

 

	 	•	 	meet on an ongoing basis the fit and proper person test for Approved Persons (which covers honesty, integrity and reputation; competence and capability; and financial soundness). 

Group Compliance has provided you with guidance on the obligations of Approved Persons and how these apply to your role as a Controlled Function holder in respect of
PAC. 

  
 11 

 Time Commitment and fees 
 Time
commitment will depend on the Committees on which you serve and may change over time, depending on the issues faced by the business and your time in the role. The Schedule to this letter provides the current time expectations for Board and Committee
membership. The Schedule is reviewed on an annual basis and may be amended from time to time by the Company. 
 Whilst we acknowledge that you have other commitments
which may mean you will not be able to attend all meetings of the Board and relevant Committees, you have confirmed by accepting this appointment that you are able to allocate sufficient time to the Company’s affairs to meet the demands of the
role. You must discuss any additional commitments that might impact on the time you are able to devote to your role as a Non-executive Director of the Company with me prior to accepting. 

Non-executive Directors’ fees are subject to annual review by the Board, and will be in accordance with the policy approved by shareholders from time to time, as
required under the Companies Act 2006 (the “Approved Policy”). Fees accrue on a daily basis and are payable quarterly in arrears. The fees currently payable for Board membership and the additional fees payable for other Committee
memberships are set out in the Schedule to this letter, as amended from time to time. All fees are payable net of any tax and National Insurance contributions, where the Company is required to deduct these. 

As a Non-executive Director you are not entitled to participate in any of the Group’s executive remuneration programmes or pension arrangements. 

Directors are entitled to claim for business related expenses properly incurred by them in connection with their attendance at meetings of the Board or Committees of the
Board, general meetings or separate meetings of the holders of any class of shares or of debentures of the Company or otherwise in connection with the discharge of their duties. Documentary evidence of expenses incurred should be submitted to my
office for approval. 
 Shareholding, dealing and compliance 
 The 2,500
Prudential qualification shares you purchased within your first year of appointment must be retained during the tenure of your office. 
 The Board has also set a
shareholding guideline for Non-executive Directors equivalent in value to the basic annual fee. This shareholding should be acquired within a three-year period of the appointment becoming effective, or from the date of the introduction of the policy
if earlier. 
 During your term in office you are subject to Prudential’s Share Dealing Rules, full particulars of which can be found in the Board Reading Room on
your iPad. The rules incorporate all relevant obligations arising from the Company’s listing in HK and the UK, as well as other relevant legislation. These are updated as required to reflect changes in legislation and regulations, and will
provide you with the necessary guidance on the steps you need to take and other considerations relating to share dealings. 
 If you have any questions on this please
consult with Group Secretariat. 

  
 12 

 Conflicts of interests, independence and disclosure obligations 

It is accepted and acknowledged that you have business interests other than those of the Company and we have discussed these and agreed that no conflicts of interest
currently exist (other than those authorised by the Board as part of the appointment process). In the event that you become aware of any future potential conflicts of interest, please disclose these to me and the Company Secretary as soon as
apparent and also prior to accepting appointments. In particular we would not wish our Directors to serve on the Boards of financial services competitors. 
 The Board
of the Company has determined that you are independent according to the provisions of the UK Corporate Governance Code and the Hong Kong Listing Rules, supported by your declaration of independence, and you will be identified as such in the annual
report and other documentation. If you are a member of the Audit Committee, you have also confirmed your independence in respect of the Securities and Exchange Act of 1934 as it applies to members of an audit committee of a Foreign Private Issuer.
If circumstances change, and you believe that your independence may be in doubt, you should discuss this with me as soon as possible. 
 The Company has an obligation
to notify details of other directorships held by its directors during the past five years to various regulators on an annual basis, together with non-statutory offices. Any changes in your external appointments, including non-statutory offices,
should be notified to the Company Secretary on an ongoing basis. In particular, any changes in your directorships of other quoted companies worldwide need to be notified promptly, preferably the next business day, as the Company is required to
announce this to various stock exchanges. 
 Wrongdoing 
 You will immediately
report to the Board your own wrongdoing or the wrongdoing or proposed wrongdoing of any employee or Director of which you become aware. 
 Termination of
appointment 
 The appointment may be terminated by and at the discretion of either party upon six months’ written notice. On termination of your appointment
you shall resign from your office as director of the Company and of any offices you hold in any of the Company’s group companies. Upon termination you will not be entitled to any compensation, other than accrued pro-rata fees, and you shall
also cease to be a member of any Committee of the Board. All records, documents, accounts, letters and papers of every description (including in particular Board and Committee agendas, minutes and papers) within your possession or control relating
to the affairs and business of the Group are and will remain the property of the Company, and shall be returned to the Company forthwith on termination. 

Notwithstanding the above, your appointment may be terminated with immediate effect if you: 
  

	(a)	commit a material breach of your obligations under this letter; or 

  
 13 

	(b)	commit any serious or repeated breach or non-observance of your obligations to the Company (which include an obligation not to breach your duties to the Company, whether statutory, fiduciary or common-law); or

  

	(c)	are guilty of any fraud or dishonesty or acted in a manner which, in the opinion of the Company acting reasonably, brings or is likely to bring you or the Company into disrepute or is materially adverse to the interests
of the Company; or 

  

	(d)	are convicted of any arrestable criminal offence other than an offence under road traffic legislation in the UK or elsewhere for which a fine or non-custodial penalty is imposed; or 

 

	(e)	are declared bankrupt or have made an arrangement with or for the benefit of your creditors; or 

  

	(f)	are disqualified from acting as a director; 

  

	(g)	cease to hold PRA Approved Person status ; or 

  

	(h)	do not comply with the Group Anti-Bribery and Corruption Policy. 

 Confidentiality 

During your appointment you will have access to confidential information regarding the business and financial affairs of the Company and those of its subsidiaries,
undertakings and affiliates. You must not, either during your appointment or afterwards, disclose to anyone or otherwise make use of this confidential information, except in the proper performance of your duties or as may be required by law or by
any competent regulatory body. This does not apply, however, to any information already in the public domain. 
 Your attention is also drawn to the requirements under
both legislation and regulation as to the disclosure of price sensitive information. Consequently you should avoid making any statements that might risk a breach of these requirements without prior clearance from me or the Company Secretary. 

Data Protection 
 By signing this letter, you consent to the Company holding and
processing information about you for legal, personnel, administrative and management purposes and in particular to the processing of any sensitive personal data (as defined in the Data Protection Act 1998) including, as appropriate: 

 

	(a)	your racial or ethnic origin or religious or similar beliefs in order to monitor compliance with equal opportunities legislation; or 

 

	(b)	information relating to any criminal proceedings in which you have been involved for insurance purposes and in order to comply with legal requirements and obligations to third parties. 

You consent to the Company making such information available to any of its group companies, those who provide products or services to the Company (such as advisers and
payroll administrators), regulatory authorities, potential or future employers, governmental or quasi-governmental organisations and potential purchasers of the Company. 

  
 14 

 You also consent to the transfer of such information to the Company’s business contacts outside the European Economic
Area in order to further its business interests. 
 Induction 
 Following your
appointment, the Company provided an induction programme which included meetings with senior management and the Company’s auditor and focussed on areas of specific interest to you. As part of your induction and during your term in office you
received briefings on your duties as a director generally and as a director of a company listed in the UK and HK. You also subsequently received a briefing on your obligations as a PRA Approved Person. 

Board evaluation 
 The performance of individual Directors and the whole Board
and its Committees is evaluated annually. If, in the interim, there are any matters which cause you concern about your role you should discuss them with me as soon as is appropriate. 

Professional development 
 As a Director you are invited to appropriate
educational and/or professional development programmes from time to time. The Company Secretary will consult each director annually to ascertain their specific professional development needs. 

Directors’ and officers’ protection 
 The Company has directors’
and officers’ liability insurance and it is intended to maintain such cover for the full term of your appointment. A brief summary of the cover can be found in Prudential’s Guidance Notes for Directors, which is updated on a regular basis.

 The Company has also provided you with indemnity cover for directors’ and officers’ liability within the limitations imposed by law. In addition, the
Company will provide you with a limited indemnity for certain personal liabilities you may suffer in the course of your appointment, subject again to applicable statutory and other limitations, pursuant to the Company’s constitutional documents
or otherwise. 
 The Board has also resolved to have a discretionary payments policy (subject to regular review), the existence of which Directors (executive and
non-executive) and certain employees or members of the Prudential Group may rely on, to protect them from personal liability arising out of the bona fide performance of their duties on behalf of the Group. 

  
 15 

 Independent professional advice 

Occasions may arise when you consider that you need professional advice in the furtherance of your duties as a Director, and it may be appropriate for you to seek advice
from independent advisers at the Company’s expense. This would normally be arranged through the Company Secretary. The Company will reimburse the full cost of expenditure incurred in accordance with the policy. Details of the agreed procedure
under which Directors may obtain such independent advice can be found in the Prudential Guidance Notes for Directors. 
 Governing law and jurisdiction 

This letter and any non-contractual obligations arising out of or in connection with it shall be governed by English law. The English courts have exclusive jurisdiction
to settle any dispute arising in respect of it. 
 Yours sincerely 
 /s/ Paul
Manduca 
 Paul Manduca 
 Chairman 

Prudential plc 

  
 16 

 Acknowledgement: 
  

	1.	By signing this letter, I agree to its terms. 

  

	2.	I acknowledge that this appointment letter does not constitute a contract of employment. 

  

	3.	I confirm that by having accepted this appointment, I am able to allocate sufficient time to meet the demands of the role. 

Signed: /s/ Ann Godbehere 
 Dated: February 2014 

  
 17 

 Ann Godbehere 

Schedule 1 – Committee memberships as at 1 July 2016 
  

	 	•	 	Audit Committee (Chairman) 

  

	 	•	 	Risk Committee 

  

	 	•	 	Nomination Committee 

 Schedule 2 – time commitment and fees as at 1 July 2016 

 

											
	 	  	 	  	Number of
regular
scheduled
meetings	 	  	Approximate
time
commitment	  	 Fees per
annum

	 Board
	  		  	 	8	 	  	31 days	  	£95,000
	 Audit Committee
	  	Chairman Member	  	 	5	 	  	22.5-27.5 days
 15 days
	  	£75,000 £27,500
	 Risk Committee
	  	Chairman Member	  	 	5	 	  	19-24 days
 7.5 days
	  	£75,000 £27,500
	 Remuneration Committee
	  	Chairman Member	  	 	4	 	  	18-23 days
 5 days
	  	£60,000 £27,500
	 Nomination Committee
	  	Member	  	 	2	 	  	4 days	  	£10,000
	 Senior Independent Director
	  		  				  	10-25 days	  	£50,000

 Note: 
 In addition to the regular scheduled
meetings, the Committees may hold additional shorter meetings as relevant to discuss, for example, periodic financial reports, succession planning and other issues as they arise. 

  
 18 

 Exhibit 4.6 

17 September 2015 
 Dear David 

PRUDENTIAL PLC - LETTER OF APPOINTMENT 
 I am delighted to confirm that the
Board of Prudential plc (the ‘Company’) has agreed to appoint you as Non-executive Director and member of the Audit Committee with effect from 15 September 2015. 

I am now writing to set out the terms of your appointment. It is agreed that this is a contract for services subject to the Company’s Articles of Association as
amended from time to time and does not constitute a contract of employment. 
 Appointment 

Your appointment is subject to election by shareholders at the AGM in 2016 and to receipt of all necessary legal and regulatory approvals. Continuation of your
appointment will be contingent on satisfactory performance, re-election at forthcoming AGMs and any statutory provisions relating to the removal of directors.
Non-executive Directors are appointed on the understanding that they serve an initial term of three years and, subject to review by the Nomination Committee, a second term of three years, both subject to
annual election at the AGM. After six years of service, Non-executive Directors may be appointed for a further year, up to a maximum of three years, subject to an annual review by the Nomination Committee.
Good governance does not support the practice of serving longer than nine years on the Board as a Non-executive Director. 
 If
you are not confirmed or re-elected as a director by shareholders, or you are retired from office under the Company’s Articles of Association, your appointment shall terminate automatically with immediate
effect. 
 Participation in Committees 

Non-executive members of the Board are invited to serve on Committees of the Board, as determined by the Board from time to time.
The principal Committees are Audit, Risk, Remuneration and Nomination. The Schedule to this letter, as amended from time to time, lists the Committees of which you are a member. 

Role 
 Non-executive Directors have the
same general legal responsibilities to the Company as any other Director. The Board as a whole is collectively responsible for the success of the Company. The Board: 

  
 19 

	•	 	Provides entrepreneurial leadership of the Company within a framework of prudent and effective controls which enable risk to be assessed and managed; 

 

	•	 	Sets the Company’s strategic aims, ensures that the necessary financial, human and other resources are in place for the Company to meet its objectives, and reviews management performance; and 

 

	•	 	Sets the Company’s values and standards and ensures that its obligations to its shareholders and others are understood and met. 

Directors of any company must take decisions objectively in the interests of that company. As a director, you owe a fiduciary duty to the Company, which includes an
obligation not to do anything that might bring it into disrepute. A summary of responsibilities of Directors as applicable to the Company under current legislation will be provided to you. 

In addition to these general requirements of all Directors, the role of the Non-executive Director has the following key
elements: 
  

	 	•	 	Strategy. Non-executive Directors should constructively challenge and help develop proposals on strategy. 

 

	 	•	 	Performance. Non-executive Directors should scrutinise the performance of management in meeting agreed goals and objectives and monitor the reporting of performance. This
is achieved both at the Board and on a more individual level through the Remuneration Committee. 

  

	 	•	 	Risk. Non-executive Directors should satisfy themselves of the integrity of financial information and that financial controls and systems of risk management are robust and
defensible. This is achieved by escalating key issues to the Board either directly or via the Audit Committee. The Group Risk Committee also has an important role in this context. 

 

	 	•	 	People. Non-executive Directors have a prime role in appointing, and where necessary removing, Executive Directors and in succession planning. In addition, they are
responsible for determining appropriate levels of remuneration for Executive Directors. This business is mainly conducted via the Nomination and Remuneration Committees. Non-executive Directors also have a
prime role in upholding high standards of integrity and probity and in supporting the other directors in instilling the appropriate culture, values and behaviours in the boardroom and beyond. 

In this role, you are a PRA Approved Person, holding a Non-executive Director controlled function (CF2) in respect of The
Prudential Assurance Company Limited (“PAC”). As an Approved Person, you must: 
  

	 	•	 	comply with the Statements of Principle and Code of Practice for Approved Persons (“APER”) set out in the APER section of the PRA Handbook; and 

 

	 	•	 	meet on an ongoing basis the fit and proper person test for Approved Persons (which covers honesty, integrity and reputation; competence and capability; and financial soundness). 

  
 20 

 Group Compliance will provide you with guidance on the obligations of Approved Persons and how these apply to your role as a
Controlled Function holder in respect of PAC. 
 Time Commitment and fees 

Time commitment will depend on the Committees on which you serve and may change over time, depending on the issues faced by the business and your time in the role. The
Schedule to this letter provides the current time expectations for Board and Committee membership. The Schedule is reviewed on an annual basis and may be amended from time to time by the Company. 

Whilst we acknowledge that you have other commitments which may mean you will not be able to attend all meetings of the Board and relevant Committees, you have confirmed
by accepting this appointment that you are able to allocate sufficient time to the Company’s affairs to meet the demands of the role. You must discuss any additional commitments that might impact on the time you are able to devote to your role
as a Non-executive Director of the Company with me prior to accepting. 
 Non-executive
Directors’ fees are subject to annual review by the Board, and will be in accordance with the policy approved by shareholders from time to time, as required under the Companies Act 2006 (the “Approved Policy”). Fees accrue on a daily
basis and are payable quarterly in arrears. The fees currently payable for Board membership and the additional fees payable for other Committee memberships are set out in the Schedule to this letter, as amended from time to time. All fees are
payable net of any tax and National Insurance contributions, where the Company is required to deduct these. 
 As a
Non-executive Director you are not entitled to participate in any of the Group’s executive remuneration programmes or pension arrangements. 

Directors are entitled to claim for business related expenses properly incurred by them in connection with their attendance at meetings of the Board or Committees of the
Board, general meetings or separate meetings of the holders of any class of shares or of debentures of the Company or otherwise in connection with the discharge of their duties. Documentary evidence of expenses incurred should be submitted to my
office for approval. 
 Shareholding, dealing and compliance 
 You are
required to hold 2,500 qualification shares in Prudential plc, which must be purchased within your first year of appointment must be retained during the tenure of your office. 

The Board has also set a shareholding guideline for Non-executive Directors equivalent in value to the basic annual fee. This
shareholding should be acquired within a three-year period of the appointment becoming effective. 
 During your term in office you are subject to Prudential’s
Share Dealing Rules, full particulars of which can be found in the Board Reading Room on your iPad. The rules incorporate all relevant obligations arising from the Company’s listing in HK and the UK, as 

  
 21 

 well as other relevant legislation. These are updated as required to reflect changes in legislation and regulations,
and will provide you with the necessary guidance on the steps you need to take and other considerations relating to share dealings. 
 If you have any questions on
this please consult with Group Secretariat. 
 Conflicts of interests, independence and disclosure obligations 

It is accepted and acknowledged that you have business interests other than those of the Company and we have discussed these and agreed that no conflicts of interest
currently exist (other than those authorised by the Board as part of the appointment process). In the event that you become aware of any future potential conflicts of interest, please disclose these to me and the Company Secretary as soon as
apparent and also prior to accepting appointments. In particular we would not wish our Directors to serve on the Boards of financial services competitors. 
 The Board
of the Company has determined that you are independent according to the provisions of the UK Corporate Governance Code and you will be identified as such in the annual report and other documentation. If you are a member of the Audit
Committee, you have also confirmed your independence in respect of the Securities and Exchange Act of 1934 as it applies to members of an audit committee of a Foreign Private Issuer. If circumstances change, and you believe that your independence
may be in doubt, you should discuss this with me as soon as possible. 
 For Hong Kong Listing Rule purposes, the Company will consider you independent from
1 July 2016, except in the event of any relevant changes. This will be supported by an independence declaration which you will be asked to provide. 
 The Company
has an obligation to notify details of other directorships held by its directors during the past five years to various regulators on an annual basis, together with non-statutory offices held in a professional
capacity. Any changes in your external appointments, including non-statutory offices, should be notified to the Company Secretary on an ongoing basis. In particular, any changes in your directorships of other
quoted companies worldwide need to be notified promptly, preferably the next business day, as the Company is required to announce this to various stock exchanges. 

Wrongdoing 
 You will immediately report to the Board your own wrongdoing or the
wrongdoing or proposed wrongdoing of any employee or Director of which you become aware. 

  
 22 

 Termination of appointment 
 The
appointment may be terminated by and at the discretion of either party upon six months’ written notice. On termination of your appointment you shall resign from your office as director of the Company and of any offices you hold in any of the
Company’s group companies. Upon termination you will not be entitled to any compensation, other than accrued pro-rata fees, and you shall also cease to be a member of any Committee of the Board. All
records, documents, accounts, letters and papers of every description (including in particular Board and Committee agendas, minutes and papers) within your possession or control relating to the affairs and business of the Group are and will remain
the property of the Company, and shall be returned to the Company forthwith on termination. 
 Notwithstanding the above, your appointment may be terminated with
immediate effect if you: 
  

	(a)	commit a material breach of your obligations under this letter; or 

  

	(b)	commit any serious or repeated breach or non-observance of your obligations to the Company (which include an obligation not to breach your duties to the Company, whether
statutory, fiduciary or common-law); or 

  

	(c)	are guilty of any fraud or dishonesty or acted in a manner which, in the opinion of the Company acting reasonably, brings or is likely to bring you or the Company into disrepute or is materially adverse to the interests
of the Company; or 

  

	(d)	are convicted of any arrestable criminal offence other than an offence under road traffic legislation in the UK or elsewhere for which a fine or non-custodial penalty is imposed;
or 

  

	(e)	are declared bankrupt or have made an arrangement with or for the benefit of your creditors; or 

  

	(f)	are disqualified from acting as a director; or 

  

	(g)	cease to hold PRA Approved Person status ; or 

  

	(h)	do not comply with the Group Anti-Bribery and Corruption Policy. 

 Confidentiality 

During your appointment you will have access to confidential information regarding the business and financial affairs of the Company and those of its subsidiaries,
undertakings and affiliates. You must not, either during your appointment or afterwards, disclose to anyone or otherwise make use of this confidential information, except in the proper performance of your duties or as may be required by law or by
any competent regulatory body. This does not apply, however, to any information already in the public domain. 
 Your attention is also drawn to the requirements under
both legislation and regulation as to the disclosure of price sensitive information. Consequently you should avoid making any statements that might risk a breach of these requirements without prior clearance from me or the Company Secretary. 

  
 23 

 Data Protection 
 By signing this
letter, you consent to the Company holding and processing information about you for legal, personnel, administrative and management purposes and in particular to the processing of any sensitive personal data (as defined in the Data Protection Act
1998) including, as appropriate: 
  

	(a)	your racial or ethnic origin or religious or similar beliefs in order to monitor compliance with equal opportunities legislation; or 

 

	(b)	information relating to any criminal proceedings in which you have been involved for insurance purposes and in order to comply with legal requirements and obligations to third parties. 

You consent to the Company making such information available to any of its group companies, those who provide products or services to the Company (such as advisers and
payroll administrators), regulatory authorities, potential or future employers, governmental or quasi-governmental organisations and potential purchasers of the Company. 

You also consent to the transfer of such information to the Company’s business contacts outside the European Economic Area in order to further its business
interests. 
 Induction 
 Following your appointment, the Company will provide
an induction programme which will include meetings with senior management and the Company’s auditor and will focus on areas of specific interest to you. As part of your induction you will receive a briefing on your duties as a director
generally and as a director of a company listed in the UK and HK. You will also receive a briefing on your obligations as a PRA Approved Person. 
 Board evaluation

 The performance of individual Directors and the whole Board and its Committees is evaluated annually. If, in the interim, there are any matters which cause you
concern about your role you should discuss them with me as soon as is appropriate. 
 Professional development 

As a Director you are invited to appropriate educational and/or professional development programmes from time to time. The Company Secretary will consult each director
annually to ascertain their specific professional development needs. The Company will also provide you with relevant briefings affecting your duties as a director. 

Directors’ and officers’ protection 
 The Company has directors’
and officers’ liability insurance and it is intended to maintain such cover for the full term of your appointment. A brief summary of the cover can be found in Prudential’s Guidance Materials for Directors, which are available on iPad.

  
 24 

 The Company has also provided you with indemnity cover for directors’ and officers’ liability within the
limitations imposed by law. In addition, the Company will provide you with a limited indemnity for certain personal liabilities you may suffer in the course of your appointment, subject again to applicable statutory and other limitations, pursuant
to the Company’s constitutional documents or otherwise. 
 In addition, the Board has resolved to have a discretionary payments policy (subject to regular
review), the existence of which Directors (executive and non-executive) and certain employees or members of the Prudential Group may rely on, to protect them from personal liability arising out of the bona
fide performance of their duties on behalf of the Group. 
 Independent professional advice 

Occasions may arise when you consider that you need professional advice in the furtherance of your duties as a Director, and it may be appropriate for you to seek advice
from independent advisers at the Company’s expense. This would normally be arranged through the Company Secretary. The Company will reimburse the full cost of expenditure incurred in accordance with the policy. Details of the agreed procedure
under which Directors may obtain such independent advice can be found in the Prudential Guidance Materials for Directors. 
 Governing law and jurisdiction 

This letter and any non-contractual obligations arising out of or in connection with it shall be governed by English law. The
English courts have exclusive jurisdiction to settle any dispute arising in respect of it. 
 Yours sincerely 

/s/ Paul Manduca 
 Paul Manduca 

Chairman 
 Prudential plc 

  
 25 

 Acknowledgement: 
  

	1.	By signing this letter, I agree to its terms. 

  

	2.	I acknowledge that this appointment letter does not constitute a contract of employment. 

  

	3.	I confirm that by having accepted this appointment, I am able to allocate sufficient time to meet the demands of the role. 

Signed: /s/ David Law 
 Dated: September 2015 

  
 26 

 David Law 
 Schedule 1
– Committee memberships as at 1 July 2016 
  

	 	•	 	Audit Committee 

 Schedule 2 – time commitment and fees as at 1 July 2016 

 

									
	 	  	 	  	Number of
regular
scheduled
meetings	  	Approximate
time
commitment	  	Fees per
annum
	 Board
	  		  	8	  	31 days	  	£95,000
	 Audit

Committee
	  	Chairman Member	  	5	  	22.5-27.5 days
 15 days
	  	£75,000
 £27,500

	 Risk

Committee
	  	Chairman Member	  	5	  	19-24 days
 7.5 days
	  	£75,000
 £27,500

	 Remuneration

Committee
	  	Chairman Member	  	4	  	18-23 days
 5 days
	  	£60,000
 £27,500

	 Nomination Committee
	  	Member	  	2	  	4 days	  	£10,000
	 Senior Independent Director
	  		  		  	10-25 days	  	£50,000

 Note: 
 In addition to the regular scheduled
meetings, the Committees may hold additional shorter meetings as relevant to discuss, for example, periodic financial reports, succession planning and other issues as they arise. 

  
 27 

 Exhibit 4.6 

13 February 2014 
 Dear Kai 

PRUDENTIAL PLC - LETTER OF APPOINTMENT 
 This letter supersedes your previous
letter of appointment dated 20 December 2011. The Board of Prudential plc (the ‘Company’) appointed you as Non-executive Director with effect from 1 January 2012. I am now writing to set
out the revised terms of your appointment. It is agreed that this is a contract for services subject to the Company’s Articles of Association as amended from time to time and does not constitute a contract of employment. 

Appointment 
 Your appointment was subject to election by shareholders at the
AGM in 2012 and to receipt of all necessary legal and regulatory approvals. Continuation of your appointment will be contingent on satisfactory performance, re-election at forthcoming AGMs and any statutory
provisions relating to the removal of directors. Non-executive Directors are appointed on the understanding that they serve an initial term of three years and, subject to review by the Nomination Committee, a
second term of three years, both subject to annual election at the AGM. After six years of service, Non-executive Directors may be appointed for a further year, up to a maximum of three years, subject to an
annual review by the Nomination Committee. Good governance does not support the practice of serving longer than nine years on the Board as a Non-executive Director. 

If you are not confirmed or re-elected as a director by shareholders, or you are retired from office under the Company’s
Articles of Association, your appointment shall terminate automatically with immediate effect. 
 Participation in Committees 

Non-executive members of the Board are invited to serve on Committees of the Board, as determined by the Board from time to time.
The principal Committees are Audit, Risk, Remuneration and Nomination. The Schedule to this letter, as amended from time to time, lists the Committees of which you are a member. 

Role 
 Non-executive Directors have the
same general legal responsibilities to the Company as any other Director. The Board as a whole is collectively responsible for the success of the Company. The Board: 
  

	•	 	Provides entrepreneurial leadership of the Company within a framework of prudent and effective controls which enable risk to be assessed and managed; 

  
 28 

	•	 	Sets the Company’s strategic aims, ensures that the necessary financial, human and other resources are in place for the Company to meet its objectives, and reviews management performance; and 

 

	•	 	Sets the Company’s values and standards and ensures that its obligations to its shareholders and others are understood and met. 

Directors of any company must take decisions objectively in the interests of that company. As a director, you owe a fiduciary duty to the Company, which includes an
obligation not to do anything that might bring it into disrepute. A summary of responsibilities of Directors as applicable to the Company under current legislation will be provided to you. 

In addition to these general requirements of all Directors, the role of the Non-executive Director has the following key
elements: 
  

	 	•	 	Strategy. Non-executive Directors should constructively challenge and help develop proposals on strategy. 

 

	 	•	 	Performance. Non-executive Directors should scrutinise the performance of management in meeting agreed goals and objectives and monitor the reporting of performance. This
is achieved both at the Board and on a more individual level through the Remuneration Committee. 

  

	 	•	 	Risk. Non-executive Directors should satisfy themselves of the integrity of financial information and that financial controls and systems of risk management are robust and
defensible. This is achieved by escalating key issues to the Board either directly or via the Audit Committee. The Group Risk Committee also has an important role in this context. 

 

	 	•	 	People. Non-executive Directors have a prime role in appointing, and where necessary removing, Executive Directors and in succession planning. In addition, they are
responsible for determining appropriate levels of remuneration for Executive Directors. This business is mainly conducted via the Nomination and Remuneration Committees. Non-executive Directors also have a
prime role in upholding high standards of integrity and probity and in supporting the other directors in instilling the appropriate culture, values and behaviours in the boardroom and beyond. 

In this role, you will be a PRA Approved Person, holding a Non-executive Director controlled function (CF2) in respect of The
Prudential Assurance Company Limited (“PAC”). As an Approved Person, you must: 
  

	 	•	 	comply with the Statements of Principle and Code of Practice for Approved Persons (“APER”) set out in the APER section of the PRA Handbook; and 

 

	 	•	 	meet on an ongoing basis the fit and proper person test for Approved Persons (which covers honesty, integrity and reputation; competence and capability; and financial soundness). 

  
 29 

 Group Compliance has provided you with guidance on the obligations of Approved Persons and how these apply to your role as a
Controlled Function holder in respect of PAC. 
 Time Commitment and fees 

Time commitment will depend on the Committees on which you serve and may change over time, depending on the issues faced by the business and your time in the role. The
Schedule to this letter provides the current time expectations for Board and Committee membership. The Schedule is reviewed on an annual basis and may be amended from time to time by the Company. 

Whilst we acknowledge that you have other commitments which may mean you will not be able to attend all meetings of the Board and relevant Committees, you have confirmed
by accepting this appointment that you are able to allocate sufficient time to the Company’s affairs to meet the demands of the role. You must discuss any additional commitments that might impact on the time you are able to devote to your role
as a Non-executive Director of the Company with me prior to accepting. 
 Non-executive
Directors’ fees are subject to annual review by the Board, and will be in accordance with the policy approved by shareholders from time to time, as required under the Companies Act 2006 (the “Approved Policy”). Fees accrue on a daily
basis and are payable quarterly in arrears. The fees currently payable for Board membership and the additional fees payable for other Committee memberships are set out in the Schedule to this letter, as amended from time to time. All fees are
payable net of any tax and National Insurance contributions, where the Company is required to deduct these. 
 As a
Non-executive Director you are not entitled to participate in any of the Group’s executive remuneration programmes or pension arrangements. 

Directors are entitled to claim for business related expenses properly incurred by them in connection with their attendance at meetings of the Board or Committees of the
Board, general meetings or separate meetings of the holders of any class of shares or of debentures of the Company or otherwise in connection with the discharge of their duties. Documentary evidence of expenses incurred should be submitted to my
office for approval. 
 Shareholding, dealing and compliance 
 The 2,500
Prudential qualification shares you purchased within your first year of appointment must be retained during the tenure of your office. 
 The Board has also set a
shareholding guideline for Non-executive Directors equivalent in value to the basic annual fee. This shareholding should be acquired within a three-year period of the appointment becoming effective, or from
the date of the introduction of the policy if earlier. 
 During your term in office you are subject to Prudential’s Share Dealing Rules, full particulars of
which can be found in the Board Reading Room on your iPad. The rules incorporate all relevant obligations arising from the Company’s listing in HK and the UK, as 

  
 30 

 well as other relevant legislation. These are updated as required to reflect changes in legislation and regulations,
and will provide you with the necessary guidance on the steps you need to take and other considerations relating to share dealings. 
 If you have any questions on
this please consult with Group Secretariat. 
 Conflicts of interests, independence and disclosure obligations 

It is accepted and acknowledged that you have business interests other than those of the Company and we have discussed these and agreed that no conflicts of interest
currently exist (other than those authorised by the Board as part of the appointment process). In the event that you become aware of any future potential conflicts of interest, please disclose these to me and the Company Secretary as soon as
apparent and also prior to accepting appointments. In particular we would not wish our Directors to serve on the Boards of financial services competitors. 
 The Board
of the Company has determined that you are independent according to the provisions of the UK Corporate Governance Code and the Hong Kong Listing Rules, supported by your declaration of independence, and you will be identified as such in the
annual report and other documentation. If you are a member of the Audit Committee, you have also confirmed your independence in respect of the Securities and Exchange Act of 1934 as it applies to members of an audit committee of a Foreign Private
Issuer. If circumstances change, and you believe that your independence may be in doubt, you should discuss this with me as soon as possible. 
 The Company has an
obligation to notify details of other directorships held by its directors during the past five years to various regulators on an annual basis, together with non-statutory offices. Any changes in your external
appointments, including non-statutory offices, should be notified to the Company Secretary on an ongoing basis. In particular, any changes in your directorships of other quoted companies worldwide need to be
notified promptly, preferably the next business day, as the Company is required to announce this to various stock exchanges. 
 Wrongdoing 

You will immediately report to the Board your own wrongdoing or the wrongdoing or proposed wrongdoing of any employee or Director of which you become aware. 

  
 31 

 Termination of appointment 
 The
appointment may be terminated by and at the discretion of either party upon six months’ written notice. On termination of your appointment you shall resign from your office as director of the Company and of any offices you hold in any of the
Company’s group companies. Upon termination you will not be entitled to any compensation, other than accrued pro-rata fees, and you shall also cease to be a member of any Committee of the Board. All records, documents, accounts, letters and
papers of every description (including in particular Board and Committee agendas, minutes and papers) within your possession or control relating to the affairs and business of the Group are and will remain the property of the Company, and shall be
returned to the Company forthwith on termination. 
 Notwithstanding the above, your appointment may be terminated with immediate effect if you: 

 

	(a)	commit a material breach of your obligations under this letter; or 

  

	(b)	commit any serious or repeated breach or non-observance of your obligations to the Company (which include an obligation not to breach your duties to the Company, whether
statutory, fiduciary or common-law); or 

  

	(c)	are guilty of any fraud or dishonesty or acted in a manner which, in the opinion of the Company acting reasonably, brings or is likely to bring you or the Company into disrepute or is materially adverse to the interests
of the Company; or 

  

	(d)	are convicted of any arrestable criminal offence other than an offence under road traffic legislation in the UK or elsewhere for which a fine or non-custodial penalty is imposed;
or 

  

	(e)	are declared bankrupt or have made an arrangement with or for the benefit of your creditors; or 

  

	(f)	are disqualified from acting as a director; 

  

	(g)	cease to hold PRA Approved Person status ; or 

  

	(h)	do not comply with the Group Anti-Bribery and Corruption Policy. 

 Confidentiality 

During your appointment you will have access to confidential information regarding the business and financial affairs of the Company and those of its subsidiaries,
undertakings and affiliates. You must not, either during your appointment or afterwards, disclose to anyone or otherwise make use of this confidential information, except in the proper performance of your duties or as may be required by law or by
any competent regulatory body. This does not apply, however, to any information already in the public domain. 
 Your attention is also drawn to the requirements under
both legislation and regulation as to the disclosure of price sensitive information. Consequently you should avoid making any statements that might risk a breach of these requirements without prior clearance from me or the Company Secretary. 

  
 32 

 Data Protection 
 By signing this
letter, you consent to the Company holding and processing information about you for legal, personnel, administrative and management purposes and in particular to the processing of any sensitive personal data (as defined in the Data Protection Act
1998) including, as appropriate: 
  

	(a)	your racial or ethnic origin or religious or similar beliefs in order to monitor compliance with equal opportunities legislation; or 

 

	(b)	information relating to any criminal proceedings in which you have been involved for insurance purposes and in order to comply with legal requirements and obligations to third parties. 

You consent to the Company making such information available to any of its group companies, those who provide products or services to the Company (such as advisers and
payroll administrators), regulatory authorities, potential or future employers, governmental or quasi-governmental organisations and potential purchasers of the Company. 

You also consent to the transfer of such information to the Company’s business contacts outside the European Economic Area in order to further its business
interests. 
 Induction 
 Following your appointment, the Company provided an
induction programme which included meetings with senior management and the Company’s auditor and focussed on areas of specific interest to you. As part of your induction and during your term in office you received briefings on your duties as a
director generally and as a director of a company listed in the UK and HK. You also subsequently received a briefing on your obligations as a PRA Approved Person. 

Board evaluation 
 The performance of individual Directors and the whole Board
and its Committees is evaluated annually. If, in the interim, there are any matters which cause you concern about your role you should discuss them with me as soon as is appropriate. 

Professional development 
 As a Director you are invited to appropriate
educational and/or professional development programmes from time to time. The Company Secretary will consult each director annually to ascertain their specific professional development needs. 

  
 33 

 Directors’ and officers’ protection 

The Company has directors’ and officers’ liability insurance and it is intended to maintain such cover for the full term of your appointment. A brief summary of
the cover can be found in Prudential’s Guidance Notes for Directors, which is updated on a regular basis. 
 The Company has also provided you with indemnity
cover for directors’ and officers’ liability within the limitations imposed by law. In addition, the Company will provide you with a limited indemnity for certain personal liabilities you may suffer in the course of your appointment,
subject again to applicable statutory and other limitations, pursuant to the Company’s constitutional documents or otherwise. 
 The Board has also resolved to
have a discretionary payments policy (subject to regular review), the existence of which Directors (executive and non-executive) and certain employees or members of the Prudential Group may rely on, to protect
them from personal liability arising out of the bona fide performance of their duties on behalf of the Group. 
 Independent professional advice 

Occasions may arise when you consider that you need professional advice in the furtherance of your duties as a Director, and it may be appropriate for you to seek advice
from independent advisers at the Company’s expense. This would normally be arranged through the Company Secretary. The Company will reimburse the full cost of expenditure incurred in accordance with the policy. Details of the agreed procedure
under which Directors may obtain such independent advice can be found in the Prudential Guidance Notes for Directors. 
 Governing law and jurisdiction 

This letter and any non-contractual obligations arising out of or in connection with it shall be governed by English law. The
English courts have exclusive jurisdiction to settle any dispute arising in respect of it. 
 Yours sincerely 

/s/ Paul Manduca 
 Paul Manduca 

Chairman 
 Prudential plc 

  
 34 

 Acknowledgement: 
  

	1.	By signing this letter, I agree to its terms. 

  

	2.	I acknowledge that this appointment letter does not constitute a contract of employment. 

  

	3.	I confirm that by having accepted this appointment, I am able to allocate sufficient time to meet the demands of the role. 

Signed: /s/ K Nargolwala 
 Dated: March 2014 

  
 35 

 Kai Nargolwala 

Schedule 1 – Committee memberships as at 1 July 2016 
  

	 	•	 	Risk Committee 

  

	 	•	 	Remuneration Committee 

 Schedule 2 – time commitment and fees as at 1 July 2016 

 

											
	 	  	 	 	  	Number of
regular
scheduled
meetings	  	Approximate
time
commitment	  	Fees per
annum
	 Board
	  				  	8	  	31 days	  	£95,000
	 Audit

Committee
	  	 
	Chairman
Member	 
 	  	5	  	22.5-27.5 days
 15 days
	  	£75,000
 £27,500

	 Risk

Committee
	  	 
	Chairman
Member	 
 	  	5	  	19-24 days
 7.5 days
	  	£75,000
 £27,500

	 Remuneration

Committee
	  	 
	Chairman
Member	 
 	  	4	  	18-23 days
 5 days
	  	£60,000
 £27,500

	 Nomination

Committee
	  	 	Member	 	  	2	  	4 days	  	£10,000
	 Senior Independent Director
	  				  		  	10-25 days	  	£50,000

 Note: 
 In addition to the regular scheduled
meetings, the Committees may hold additional shorter meetings as relevant to discuss, for example, periodic financial reports, succession planning and other issues as they arise. 

  
 36 

 Exhibit 4.6 

13 February 2014 
 Dear Anthony, 

PRUDENTIAL PLC - LETTER OF APPOINTMENT 
 This letter supersedes your previous
letter of appointment dated 28 May 2013. The Board of Prudential plc (the ‘Company’) appointed you as Non-executive Director with effect from 1 June 2013. I am now writing to set out the
revised terms of your appointment. It is agreed that this is a contract for services subject to the Company’s Articles of Association as amended from time to time and does not constitute a contract of employment. 

Appointment 
 Your appointment is subject to election by shareholders at the AGM
in 2014 and to receipt of all necessary legal and regulatory approvals. Continuation of your appointment will be contingent on satisfactory performance, re-election at forthcoming AGMs and any statutory
provisions relating to the removal of directors. Non-executive Directors are appointed on the understanding that they serve an initial term of three years and, subject to review by the Nomination Committee, a
second term of three years, both subject to annual election at the AGM. After six years of service, Non-executive Directors may be appointed for a further year, up to a maximum of three years, subject to an
annual review by the Nomination Committee. Good governance does not support the practice of serving longer than nine years on the Board as a Non-executive Director. 

If you are not confirmed or re-elected as a director by shareholders, or you are retired from office under the Company’s
Articles of Association, your appointment shall terminate automatically with immediate effect. 
 Participation in Committees 

Non-executive members of the Board are invited to serve on Committees of the Board, as determined by the Board from time to time.
The principal Committees are Audit, Risk, Remuneration and Nomination. The Schedule to this letter, as amended from time to time, lists the Committees of which you are a member. 

Role 
 Non-executive Directors have the
same general legal responsibilities to the Company as any other Director. The Board as a whole is collectively responsible for the success of the Company. The Board: 

  
 37 

	•	 	Provides entrepreneurial leadership of the Company within a framework of prudent and effective controls which enable risk to be assessed and managed; 

 

	•	 	Sets the Company’s strategic aims, ensures that the necessary financial, human and other resources are in place for the Company to meet its objectives, and reviews management performance; and 

 

	•	 	Sets the Company’s values and standards and ensures that its obligations to its shareholders and others are understood and met. 

Directors of any company must take decisions objectively in the interests of that company. As a director, you owe a fiduciary duty to the Company, which includes an
obligation not to do anything that might bring it into disrepute. A summary of responsibilities of Directors as applicable to the Company under current legislation will be provided to you. 

In addition to these general requirements of all Directors, the role of the Non-executive Director has the following key
elements: 
  

	 	•	 	Strategy. Non-executive Directors should constructively challenge and help develop proposals on strategy. 

 

	 	•	 	Performance. Non-executive Directors should scrutinise the performance of management in meeting agreed goals and objectives and monitor the reporting of performance. This
is achieved both at the Board and on a more individual level through the Remuneration Committee. 

  

	 	•	 	Risk. Non-executive Directors should satisfy themselves of the integrity of financial information and that financial controls and systems of risk management are robust and
defensible. This is achieved by escalating key issues to the Board either directly or via the Audit Committee. The Group Risk Committee also has an important role in this context. 

 

	 	•	 	People. Non-executive Directors have a prime role in appointing, and where necessary removing, Executive Directors and in succession planning. In addition, they are
responsible for determining appropriate levels of remuneration for Executive Directors. This business is mainly conducted via the Nomination and Remuneration Committees. Non-executive Directors also have a
prime role in upholding high standards of integrity and probity and in supporting the other directors in instilling the appropriate culture, values and behaviours in the boardroom and beyond. 

In this role, you will be a PRA Approved Person, holding a Non-executive Director controlled function (CF2) in respect of The
Prudential Assurance Company Limited (“PAC”). As an Approved Person, you must: 
  

	 	•	 	comply with the Statements of Principle and Code of Practice for Approved Persons (“APER”) set out in the APER section of the PRA Handbook; and 

  
 38 

	 	•	 	meet on an ongoing basis the fit and proper person test for Approved Persons (which covers honesty, integrity and reputation; competence and capability; and financial soundness). 

Group Compliance has provided you with guidance on the obligations of Approved Persons and how these apply to your role as a Controlled Function holder in respect of
PAC. 
 Time Commitment and fees 
 Time commitment will depend on the
Committees on which you serve and may change over time, depending on the issues faced by the business and your time in the role. The Schedule to this letter provides the current time expectations for Board and Committee membership. The Schedule is
reviewed on an annual basis and may be amended from time to time by the Company. 
 Whilst we acknowledge that you have other commitments which may mean you will not
be able to attend all meetings of the Board and relevant Committees, you have confirmed by accepting this appointment that you are able to allocate sufficient time to the Company’s affairs to meet the demands of the role. You must discuss any
additional commitments that might impact on the time you are able to devote to your role as a Non-executive Director of the Company with me prior to accepting. 

Non-executive Directors’ fees are subject to annual review by the Board, and will be in accordance with the policy approved
by shareholders from time to time, as required under the Companies Act 2006 (the “Approved Policy”). Fees accrue on a daily basis and are payable quarterly in arrears. The fees currently payable for Board membership and the additional fees
payable for other Committee memberships are set out in the Schedule to this letter, as amended from time to time. All fees are payable net of any tax and National Insurance contributions, where the Company is required to deduct these. 

As a Non-executive Director you are not entitled to participate in any of the Group’s executive remuneration programmes or
pension arrangements. 
 Directors are entitled to claim for business related expenses properly incurred by them in connection with their attendance at meetings of the
Board or Committees of the Board, general meetings or separate meetings of the holders of any class of shares or of debentures of the Company or otherwise in connection with the discharge of their duties. Documentary evidence of expenses incurred
should be submitted to my office for approval. 
 Shareholding, dealing and compliance 

The 2,500 Prudential qualification shares you purchased within your first year of appointment must be retained during the tenure of your office. 

The Board has also set a shareholding guideline for Non-executive Directors equivalent in value to the basic annual fee. This
shareholding should be acquired within a three-year period of the appointment becoming effective, or from the date of the introduction of the policy if earlier. 

  
 39 

 During your term in office you are subject to Prudential’s Share Dealing Rules, full particulars of which can be found
in the Board Reading Room on your iPad. The rules incorporate all relevant obligations arising from the Company’s listing in HK and the UK, as well as other relevant legislation. These are updated as required to reflect changes in
legislation and regulations, and will provide you with the necessary guidance on the steps you need to take and other considerations relating to share dealings. 
 If
you have any questions on this please consult with Group Secretariat. 
 Conflicts of interests, independence and disclosure obligations 

It is accepted and acknowledged that you have business interests other than those of the Company and we have discussed these and agreed that no conflicts of interest
currently exist (other than those authorised by the Board as part of the appointment process). In the event that you become aware of any future potential conflicts of interest, please disclose these to me and the Company Secretary as soon as
apparent and also prior to accepting appointments. In particular we would not wish our Directors to serve on the Boards of financial services competitors. 
 The Board
of the Company has determined that you are independent according to the provisions of the UK Corporate Governance Code and the Hong Kong Listing Rules, supported by your declaration of independence, and you will be identified as such in the
annual report and other documentation. If you are a member of the Audit Committee, you have also confirmed your independence in respect of the Securities and Exchange Act of 1934 as it applies to members of an audit committee of a Foreign Private
Issuer. If circumstances change, and you believe that your independence may be in doubt, you should discuss this with me as soon as possible. 
 The Company has an
obligation to notify details of other directorships held by its directors during the past five years to various regulators on an annual basis, together with non-statutory offices. Any changes in your external
appointments, including non-statutory offices, should be notified to the Company Secretary on an ongoing basis. In particular, any changes in your directorships of other quoted companies worldwide need to be
notified promptly, preferably the next business day, as the Company is required to announce this to various stock exchanges. 
 Wrongdoing 

You will immediately report to the Board your own wrongdoing or the wrongdoing or proposed wrongdoing of any employee or Director of which you become aware. 

  
 40 

 Termination of appointment 
 The
appointment may be terminated by and at the discretion of either party upon six months’ written notice. On termination of your appointment you shall resign from your office as director of the Company and of any offices you hold in any of the
Company’s group companies. Upon termination you will not be entitled to any compensation, other than accrued pro-rata fees, and you shall also cease to be a member of any Committee of the Board. All
records, documents, accounts, letters and papers of every description (including in particular Board and Committee agendas, minutes and papers) within your possession or control relating to the affairs and business of the Group are and will remain
the property of the Company, and shall be returned to the Company forthwith on termination. 
 Notwithstanding the above, your appointment may be terminated with
immediate effect if you: 
  

	(a)	commit a material breach of your obligations under this letter; or 

  

	(b)	commit any serious or repeated breach or non-observance of your obligations to the Company (which include an obligation not to breach your duties to the Company, whether
statutory, fiduciary or common-law); or 

  

	(c)	are guilty of any fraud or dishonesty or acted in a manner which, in the opinion of the Company acting reasonably, brings or is likely to bring you or the Company into disrepute or is materially adverse to the interests
of the Company; or 

  

	(d)	are convicted of any arrestable criminal offence other than an offence under road traffic legislation in the UK or elsewhere for which a fine or non-custodial penalty is imposed;
or 

  

	(e)	are declared bankrupt or have made an arrangement with or for the benefit of your creditors; or 

  

	(f)	are disqualified from acting as a director; 

  

	(g)	cease to hold PRA Approved Person status ; or 

  

	(h)	do not comply with the Group Anti-Bribery and Corruption Policy. 

 Confidentiality 

During your appointment you will have access to confidential information regarding the business and financial affairs of the Company and those of its subsidiaries,
undertakings and affiliates. You must not, either during your appointment or afterwards, disclose to anyone or otherwise make use of this confidential information, except in the proper performance of your duties or as may be required by law or by
any competent regulatory body. This does not apply, however, to any information already in the public domain. 
 Your attention is also drawn to the requirements under
both legislation and regulation as to the disclosure of price sensitive information. Consequently you should avoid making any statements that might risk a breach of these requirements without prior clearance from me or the Company Secretary. 

  
 41 

 Data Protection 
 By signing this
letter, you consent to the Company holding and processing information about you for legal, personnel, administrative and management purposes and in particular to the processing of any sensitive personal data (as defined in the Data Protection Act
1998) including, as appropriate: 
  

	(a)	your racial or ethnic origin or religious or similar beliefs in order to monitor compliance with equal opportunities legislation; or 

 

	(b)	information relating to any criminal proceedings in which you have been involved for insurance purposes and in order to comply with legal requirements and obligations to third parties. 

You consent to the Company making such information available to any of its group companies, those who provide products or services to the Company (such as advisers and
payroll administrators), regulatory authorities, potential or future employers, governmental or quasi-governmental organisations and potential purchasers of the Company. 

You also consent to the transfer of such information to the Company’s business contacts outside the European Economic Area in order to further its business
interests. 
 Induction 
 Following your appointment, the Company provided an
induction programme which included meetings with senior management and the Company’s auditor and focussed on areas of specific interest to you. As part of your induction and during your term in office you received briefings on your duties as a
director generally and as a director of a company listed in the UK and HK. You also subsequently received a briefing on your obligations as a PRA Approved Person. 

Board evaluation 
 The performance of individual Directors and the whole Board
and its Committees is evaluated annually. If, in the interim, there are any matters which cause you concern about your role you should discuss them with me as soon as is appropriate. 

Professional development 
 As a Director you are invited to appropriate
educational and/or professional development programmes from time to time. The Company Secretary will consult each director annually to ascertain their specific professional development needs. 

  
 42 

 Directors’ and officers’ protection 

The Company has directors’ and officers’ liability insurance and it is intended to maintain such cover for the full term of your appointment. A brief summary of
the cover can be found in Prudential’s Guidance Notes for Directors, which is updated on a regular basis. 
 The Company has also provided you with indemnity
cover for directors’ and officers’ liability within the limitations imposed by law. In addition, the Company will provide you with a limited indemnity for certain personal liabilities you may suffer in the course of your appointment,
subject again to applicable statutory and other limitations, pursuant to the Company’s constitutional documents or otherwise. 
 The Board has also resolved to
have a discretionary payments policy (subject to regular review), the existence of which Directors (executive and non-executive) and certain employees or members of the Prudential Group may rely on, to protect
them from personal liability arising out of the bona fide performance of their duties on behalf of the Group. 
 Independent professional advice 

Occasions may arise when you consider that you need professional advice in the furtherance of your duties as a Director, and it may be appropriate for you to seek advice
from independent advisers at the Company’s expense. This would normally be arranged through the Company Secretary. The Company will reimburse the full cost of expenditure incurred in accordance with the policy. Details of the agreed procedure
under which Directors may obtain such independent advice can be found in the Prudential Guidance Notes for Directors. 
 Governing law and jurisdiction 

This letter and any non-contractual obligations arising out of or in connection with it shall be governed by English law. The
English courts have exclusive jurisdiction to settle any dispute arising in respect of it. 
 Yours sincerely 

/s/ Paul Manduca 
 Paul Manduca 

Chairman 
 Prudential plc 

  
 43 

 Acknowledgement: 
  

	1.	By signing this letter, I agree to its terms. 

  

	2.	I acknowledge that this appointment letter does not constitute a contract of employment. 

  

	3.	I confirm that by having accepted this appointment, I am able to allocate sufficient time to meet the demands of the role. 

Signed: /s/ Anthony Nightingale 
 Dated: 23.02.2014 

  
 44 

 Anthony Nightingale 

Schedule 1 – Committee memberships as at 1 July 2016 
  

	 	•	 	Remuneration Committee (Chairman) 

  

	 	•	 	Nomination Committee 

 Schedule 2 – time commitment and fees as at 1 July 2016 

 

													
	 	  	 	 	  	Number of
regular
scheduled
meetings	  	Approximate
time
commitment	  	Fees per
annum	 
	 Board
	  				  	8	  	31 days	  	£	95,000	 
	 Audit

Committee
	  	 
	Chairman
Member	 
 	  	5	  	22.5-27.5 days
 15 days
	  	£
 £
	75,000
 27,500
	 
  

	 Risk

Committee
	  	 
	Chairman
Member	 
 	  	5	  	19-24 days
 7.5 days
	  	£
 £
	75,000
 27,500
	 
  

	 Remuneration

Committee
	  	 
	Chairman
Member	 
 	  	4	  	18-23 days
 5 days
	  	£
 £
	60,000
 27,500
	 
  

	 Nomination

Committee
	  	 	Member	 	  	2	  	4 days	  	£	10,000	 
	 Senior Independent Director
	  				  		  	10-25 days	  	£	50,000	 

 Note: 
 In addition to the regular scheduled
meetings, the Committees may hold additional shorter meetings as relevant to discuss, for example, periodic financial reports, succession planning and other issues as they arise. 

  
 45 

 Exhibit 4.6 

13 February 2014 
 Dear Philip 

PRUDENTIAL PLC - LETTER OF APPOINTMENT 
 This letter supersedes your previous
letter of appointment dated 19 December 2012. The Board of Prudential plc (the ‘Company’) appointed you as Non-executive Director with effect from 1 January 2013. I am now writing to set out the revised terms of your appointment.
It is agreed that this is a contract for services subject to the Company’s Articles of Association as amended from time to time and does not constitute a contract of employment. 

Appointment 
 Your appointment was subject to election by shareholders at the
AGM in 2013 and to receipt of all necessary legal and regulatory approvals. Continuation of your appointment will be contingent on satisfactory performance, re-election at forthcoming AGMs and any statutory provisions relating to the removal of
directors. Non-executive Directors are appointed on the understanding that they serve an initial term of three years and, subject to review by the Nomination Committee, a second term of three years, both subject to annual election at the AGM. After
six years of service, Non-executive Directors may be appointed for a further year, up to a maximum of three years, subject to an annual review by the Nomination Committee. Good governance does not support the practice of serving longer than nine
years on the Board as a Non-executive Director. 
 If you are not confirmed or re-elected as a director by shareholders, or you are retired from office under the
Company’s Articles of Association, your appointment shall terminate automatically with immediate effect. 
 Participation in Committees 

Non-executive members of the Board are invited to serve on Committees of the Board, as determined by the Board from time to time. The principal Committees are Audit,
Risk, Remuneration and Nomination. The Schedule to this letter, as amended from time to time, lists the Committees of which you are a member. 
 Role 

Non-executive Directors have the same general legal responsibilities to the Company as any other Director. The Board as a whole is collectively responsible for the
success of the Company. The Board: 

  
 46 

	•	 	Provides entrepreneurial leadership of the Company within a framework of prudent and effective controls which enable risk to be assessed and managed; 

 

	•	 	Sets the Company’s strategic aims, ensures that the necessary financial, human and other resources are in place for the Company to meet its objectives, and reviews management performance; and 

 

	•	 	Sets the Company’s values and standards and ensures that its obligations to its shareholders and others are understood and met. 

Directors of any company must take decisions objectively in the interests of that company. As a director, you owe a fiduciary duty to the Company, which includes an
obligation not to do anything that might bring it into disrepute. A summary of responsibilities of Directors as applicable to the Company under current legislation will be provided to you. 

In addition to these general requirements of all Directors, the role of the Non-executive Director has the following key elements: 

 

	 	•	 	Strategy. Non-executive Directors should constructively challenge and help develop proposals on strategy. 

  

	 	•	 	Performance. Non-executive Directors should scrutinise the performance of management in meeting agreed goals and objectives and monitor the reporting of performance. This is achieved both at the Board and on a
more individual level through the Remuneration Committee. 

  

	 	•	 	Risk. Non-executive Directors should satisfy themselves of the integrity of financial information and that financial controls and systems of risk management are robust and defensible. This is achieved by
escalating key issues to the Board either directly or via the Audit Committee. The Group Risk Committee also has an important role in this context. 

  

	 	•	 	People. Non-executive Directors have a prime role in appointing, and where necessary removing, Executive Directors and in succession planning. In addition, they are responsible for determining appropriate levels
of remuneration for Executive Directors. This business is mainly conducted via the Nomination and Remuneration Committees. Non-executive Directors also have a prime role in upholding high standards of integrity and probity and in supporting the
other directors in instilling the appropriate culture, values and behaviours in the boardroom and beyond. 

 In this role, you will be a PRA Approved
Person, holding a Non-executive Director controlled function (CF2) in respect of The Prudential Assurance Company Limited (“PAC”). As an Approved Person, you must: 
  

	 	•	 	comply with the Statements of Principle and Code of Practice for Approved Persons (“APER”) set out in the APER section of the PRA Handbook; and 

 

	 	•	 	meet on an ongoing basis the fit and proper person test for Approved Persons (which covers honesty, integrity and reputation; competence and capability; and financial soundness). 

  
 47 

 Group Compliance has provided you with guidance on the obligations of Approved Persons and how these apply to your role as a
Controlled Function holder in respect of PAC. 
 Time Commitment and fees 

Time commitment will depend on the Committees on which you serve and may change over time, depending on the issues faced by the business and your time in the role. The
Schedule to this letter provides the current time expectations for Board and Committee membership. The Schedule is reviewed on an annual basis and may be amended from time to time by the Company. 

Whilst we acknowledge that you have other commitments which may mean you will not be able to attend all meetings of the Board and relevant Committees, you have confirmed
by accepting this appointment that you are able to allocate sufficient time to the Company’s affairs to meet the demands of the role. You must discuss any additional commitments that might impact on the time you are able to devote to your role
as a Non-executive Director of the Company with me prior to accepting. 
 Non-executive Directors’ fees are subject to annual review by the Board, and will be in
accordance with the policy approved by shareholders from time to time, as required under the Companies Act 2006 (the “Approved Policy”). Fees accrue on a daily basis and are payable quarterly in arrears. The fees currently payable for
Board membership and the additional fees payable for other Committee memberships are set out in the Schedule to this letter, as amended from time to time. All fees are payable net of any tax and National Insurance contributions, where the Company is
required to deduct these. 
 As a Non-executive Director you are not entitled to participate in any of the Group’s executive remuneration programmes or pension
arrangements. 
 Directors are entitled to claim for business related expenses properly incurred by them in connection with their attendance at meetings of the Board
or Committees of the Board, general meetings or separate meetings of the holders of any class of shares or of debentures of the Company or otherwise in connection with the discharge of their duties. Documentary evidence of expenses incurred should
be submitted to my office for approval. 
 Senior Independent Director 
 You
have also been appointed to the role of Senior Independent Director and the additional time commitment and fees are set out in the Schedule, as amended from time to time. 

Shareholding, dealing and compliance 
 The 2,500 Prudential qualification shares
you purchased within your first year of appointment must be retained during the tenure of your office. 
 The Board has also set a shareholding guideline for
Non-executive Directors equivalent in value to the basic annual fee. This shareholding should be acquired within a three-year period of the appointment becoming effective, or from the date of the introduction of the policy if earlier. 

  
 48 

 During your term in office you are subject to Prudential’s Share Dealing Rules, full particulars of which can be found
in the Board Reading Room on your iPad. The rules incorporate all relevant obligations arising from the Company’s listing in HK and the UK, as well as other relevant legislation. These are updated as required to reflect changes in
legislation and regulations, and will provide you with the necessary guidance on the steps you need to take and other considerations relating to share dealings. 
 If
you have any questions on this please consult with Group Secretariat. 
 Conflicts of interests, independence and disclosure obligations 

It is accepted and acknowledged that you have business interests other than those of the Company and we have discussed these and agreed that no conflicts of interest
currently exist (other than those authorised by the Board as part of the appointment process). In the event that you become aware of any future potential conflicts of interest, please disclose these to me and the Company Secretary as soon as
apparent and also prior to accepting appointments. In particular we would not wish our Directors to serve on the Boards of financial services competitors. 
 The Board
of the Company has determined that you are independent according to the provisions of the UK Corporate Governance Code and the Hong Kong Listing Rules, supported by your declaration of independence, and you will be identified as such in the annual
report and other documentation. If you are a member of the Audit Committee, you have also confirmed your independence in respect of the Securities and Exchange Act of 1934 as it applies to members of an audit committee of a Foreign Private Issuer.
If circumstances change, and you believe that your independence may be in doubt, you should discuss this with me as soon as possible. 
 The Company has an obligation
to notify details of other directorships held by its directors during the past five years to various regulators on an annual basis, together with non-statutory offices. Any changes in your external appointments, including non-statutory offices,
should be notified to the Company Secretary on an ongoing basis. In particular, any changes in your directorships of other quoted companies worldwide need to be notified promptly, preferably the next business day, as the Company is required to
announce this to various stock exchanges. 
 Wrongdoing 
 You will immediately
report to the Board your own wrongdoing or the wrongdoing or proposed wrongdoing of any employee or Director of which you become aware. 

  
 49 

 Termination of appointment 
 The
appointment may be terminated by and at the discretion of either party upon six months’ written notice. On termination of your appointment you shall resign from your office as director of the Company and of any offices you hold in any of the
Company’s group companies. Upon termination you will not be entitled to any compensation, other than accrued pro-rata fees, and you shall also cease to be a member of any Committee of the Board. All records, documents, accounts, letters and
papers of every description (including in particular Board and Committee agendas, minutes and papers) within your possession or control relating to the affairs and business of the Group are and will remain the property of the Company, and shall be
returned to the Company forthwith on termination. 
 Notwithstanding the above, your appointment may be terminated with immediate effect if you: 

 

	(a)	commit a material breach of your obligations under this letter; or 

  

	(b)	commit any serious or repeated breach or non-observance of your obligations to the Company (which include an obligation not to breach your duties to the Company, whether statutory, fiduciary or common-law); or

  

	(c)	are guilty of any fraud or dishonesty or acted in a manner which, in the opinion of the Company acting reasonably, brings or is likely to bring you or the Company into disrepute or is materially adverse to the interests
of the Company; or 

  

	(d)	are convicted of any arrestable criminal offence other than an offence under road traffic legislation in the UK or elsewhere for which a fine or non-custodial penalty is imposed; or 

 

	(e)	are declared bankrupt or have made an arrangement with or for the benefit of your creditors; or 

  

	(f)	are disqualified from acting as a director; 

  

	(g)	cease to hold PRA Approved Person status ; or 

  

	(h)	do not comply with the Group Anti-Bribery and Corruption Policy. 

 Confidentiality 

During your appointment you will have access to confidential information regarding the business and financial affairs of the Company and those of its subsidiaries,
undertakings and affiliates. You must not, either during your appointment or afterwards, disclose to anyone or otherwise make use of this confidential information, except in the proper performance of your duties or as may be required by law or by
any competent regulatory body. This does not apply, however, to any information already in the public domain. 
 Your attention is also drawn to the requirements under
both legislation and regulation as to the disclosure of price sensitive information. Consequently you should avoid making any statements that might risk a breach of these requirements without prior clearance from me or the Company Secretary. 

  
 50 

 Data Protection 
 By signing this
letter, you consent to the Company holding and processing information about you for legal, personnel, administrative and management purposes and in particular to the processing of any sensitive personal data (as defined in the Data Protection Act
1998) including, as appropriate: 
  

	(a)	your racial or ethnic origin or religious or similar beliefs in order to monitor compliance with equal opportunities legislation; or 

 

	(b)	information relating to any criminal proceedings in which you have been involved for insurance purposes and in order to comply with legal requirements and obligations to third parties. 

You consent to the Company making such information available to any of its group companies, those who provide products or services to the Company (such as advisers and
payroll administrators), regulatory authorities, potential or future employers, governmental or quasi-governmental organisations and potential purchasers of the Company. 

You also consent to the transfer of such information to the Company’s business contacts outside the European Economic Area in order to further its business
interests. 
 Induction 
 Following your appointment, the Company provided an
induction programme which included meetings with senior management and the Company’s auditor and focussed on areas of specific interest to you. As part of your induction and during your term in office you received briefings on your duties as a
director generally and as a director of a company listed in the UK and HK. You also subsequently received a briefing on your obligations as a PRA Approved Person. 

Board evaluation 
 The performance of individual Directors and the whole Board
and its Committees is evaluated annually. If, in the interim, there are any matters which cause you concern about your role you should discuss them with me as soon as is appropriate. 

Professional development 
 As a Director you are invited to appropriate
educational and/or professional development programmes from time to time. The Company Secretary will consult each director annually to ascertain their specific professional development needs. 

  
 51 

 Directors’ and officers’ protection 

The Company has directors’ and officers’ liability insurance and it is intended to maintain such cover for the full term of your appointment. A brief summary of
the cover can be found in Prudential’s Guidance Notes for Directors, which is updated on a regular basis. 
 The Company has also provided you with indemnity
cover for directors’ and officers’ liability within the limitations imposed by law. In addition, the Company will provide you with a limited indemnity for certain personal liabilities you may suffer in the course of your appointment,
subject again to applicable statutory and other limitations, pursuant to the Company’s constitutional documents or otherwise. 
 The Board has also resolved to
have a discretionary payments policy (subject to regular review), the existence of which Directors (executive and non-executive) and certain employees or members of the Prudential Group may rely on, to protect them from personal liability arising
out of the bona fide performance of their duties on behalf of the Group. 
 Independent professional advice 

Occasions may arise when you consider that you need professional advice in the furtherance of your duties as a Director, and it may be appropriate for you to seek advice
from independent advisers at the Company’s expense. This would normally be arranged through the Company Secretary. The Company will reimburse the full cost of expenditure incurred in accordance with the policy. Details of the agreed procedure
under which Directors may obtain such independent advice can be found in the Prudential Guidance Notes for Directors. 
 Governing law and jurisdiction 

This letter and any non-contractual obligations arising out of or in connection with it shall be governed by English law. The English courts have exclusive jurisdiction
to settle any dispute arising in respect of it. 
 Yours sincerely 
 /s/ Paul
Manduca 
 Paul Manduca 
 Chairman 

Prudential plc 

  
 52 

 Acknowledgement: 
  

	1.	By signing this letter, I agree to its terms. 

  

	2.	I acknowledge that this appointment letter does not constitute a contract of employment. 

  

	3.	I confirm that by having accepted this appointment, I am able to allocate sufficient time to meet the demands of the role. 

Signed:/s/ Philip Remnant 
 Dated: February 2014 

  
 53 

 Hon P J Remnant 

Schedule 1 – Committee memberships as at 1 July 2016 
  

	 	•	 	Audit Committee 

  

	 	•	 	Remuneration Committee 

  

	 	•	 	Nomination Committee 

  

	 	•	 	Senior Independent Director 

 Schedule 2 – time commitment and fees as at 1 July 2016 

 

											
	 	  	 	  	Number of
regular
scheduled
meetings	 	  	Approximate
time
commitment	  	 Fees per
annum

	 Board
	  		  	 	8	 	  	31 days	  	£95,000
	 Audit Committee
	  	Chairman Member	  	 	5	 	  	22.5-27.5 days
 15 days
	  	£75,000 £27,500
	 Risk Committee
	  	Chairman Member	  	 	5	 	  	19-24 days
 7.5 days
	  	£75,000 £27,500
	 Remuneration Committee
	  	Chairman Member	  	 	4	 	  	18-23 days
 5 days
	  	£60,000 £27,500
	 Nomination Committee
	  	Member	  	 	2	 	  	4 days	  	£10,000
	 Senior Independent Director
	  		  				  	10-25 days	  	£50,000

 Note: 
 In addition to the regular scheduled
meetings, the Committees may hold additional shorter meetings as relevant to discuss, for example, periodic financial reports, succession planning and other issues as they arise. 

  
 54 

 Exhibit 4.6 

13 February 2014 
 Dear Alice 

PRUDENTIAL PLC - LETTER OF APPOINTMENT 
 This letter supersedes your previous
letter of appointment dated 12 June 2013. The Board of Prudential plc (the ‘Company’) appointed you as Non-executive Director with effect from 10 June 2013. I am now writing to set out the revised terms of your appointment. It is
agreed that this is a contract for services subject to the Company’s Articles of Association as amended from time to time and does not constitute a contract of employment. 

Appointment 
 Your appointment is subject to election by shareholders at the AGM
in 2014 and to receipt of all necessary legal and regulatory approvals. Continuation of your appointment will be contingent on satisfactory performance, re-election at forthcoming AGMs and any statutory provisions relating to the removal of
directors. Non-executive Directors are appointed on the understanding that they serve an initial term of three years and, subject to review by the Nomination Committee, a second term of three years, both subject to annual election at the AGM. After
six years of service, Non-executive Directors may be appointed for a further year, up to a maximum of three years, subject to an annual review by the Nomination Committee. Good governance does not support the practice of serving longer than nine
years on the Board as a Non-executive Director. 
 If you are not confirmed or re-elected as a director by shareholders, or you are retired from office under the
Company’s Articles of Association, your appointment shall terminate automatically with immediate effect. 
 Participation in Committees 

Non-executive members of the Board are invited to serve on Committees of the Board, as determined by the Board from time to time. The principal Committees are Audit,
Risk, Remuneration and Nomination. The Schedule to this letter, as amended from time to time, lists the Committees of which you are a member. 

  
 55 

 Role 
 Non-executive Directors have
the same general legal responsibilities to the Company as any other Director. The Board as a whole is collectively responsible for the success of the Company. The Board: 
  

	•	 	Provides entrepreneurial leadership of the Company within a framework of prudent and effective controls which enable risk to be assessed and managed; 

 

	•	 	Sets the Company’s strategic aims, ensures that the necessary financial, human and other resources are in place for the Company to meet its objectives, and reviews management performance; and 

 

	•	 	Sets the Company’s values and standards and ensures that its obligations to its shareholders and others are understood and met. 

Directors of any company must take decisions objectively in the interests of that company. As a director, you owe a fiduciary duty to the Company, which includes an
obligation not to do anything that might bring it into disrepute. A summary of responsibilities of Directors as applicable to the Company under current legislation will be provided to you. 

In addition to these general requirements of all Directors, the role of the Non-executive Director has the following key elements: 

 

	 	•	 	Strategy. Non-executive Directors should constructively challenge and help develop proposals on strategy. 

  

	 	•	 	Performance. Non-executive Directors should scrutinise the performance of management in meeting agreed goals and objectives and monitor the reporting of performance. This is achieved both at the Board and on a
more individual level through the Remuneration Committee. 

  

	 	•	 	Risk. Non-executive Directors should satisfy themselves of the integrity of financial information and that financial controls and systems of risk management are robust and defensible. This is achieved by
escalating key issues to the Board either directly or via the Audit Committee. The Group Risk Committee also has an important role in this context. 

  

	 	•	 	People. Non-executive Directors have a prime role in appointing, and where necessary removing, Executive Directors and in succession planning. In addition, they are responsible for determining appropriate levels
of remuneration for Executive Directors. This business is mainly conducted via the Nomination and Remuneration Committees. Non-executive Directors also have a prime role in upholding high standards of integrity and probity and in supporting the
other directors in instilling the appropriate culture, values and behaviours in the boardroom and beyond. 

 In this role, you will be a PRA Approved
Person, holding a Non-executive Director controlled function (CF2) in respect of The Prudential Assurance Company Limited (“PAC”). As an Approved Person, you must: 
  

	 	•	 	comply with the Statements of Principle and Code of Practice for Approved Persons (“APER”) set out in the APER section of the PRA Handbook; and 

 

	 	•	 	meet on an ongoing basis the fit and proper person test for Approved Persons (which covers honesty, integrity and reputation; competence and capability; and financial soundness). 

  
 56 

 Group Compliance has provided you with guidance on the obligations of Approved Persons and how these apply to your role as a
Controlled Function holder in respect of PAC. 
 Time Commitment and fees 

Time commitment will depend on the Committees on which you serve and may change over time, depending on the issues faced by the business and your time in the role. The
Schedule to this letter provides the current time expectations for Board and Committee membership. The Schedule is reviewed on an annual basis and may be amended from time to time by the Company. 

Whilst we acknowledge that you have other commitments which may mean you will not be able to attend all meetings of the Board and relevant Committees, you have confirmed
by accepting this appointment that you are able to allocate sufficient time to the Company’s affairs to meet the demands of the role. You must discuss any additional commitments that might impact on the time you are able to devote to your role
as a Non-executive Director of the Company with me prior to accepting. 
 Non-executive Directors’ fees are subject to annual review by the Board, and will be in
accordance with the policy approved by shareholders from time to time, as required under the Companies Act 2006 (the “Approved Policy”). Fees accrue on a daily basis and are payable quarterly in arrears. The fees currently payable for
Board membership and the additional fees payable for other Committee memberships are set out in the Schedule to this letter, as amended from time to time. All fees are payable net of any tax and National Insurance contributions, where the Company is
required to deduct these. 
 As a Non-executive Director you are not entitled to participate in any of the Group’s executive remuneration programmes or pension
arrangements. 
 Directors are entitled to claim for business related expenses properly incurred by them in connection with their attendance at meetings of the Board
or Committees of the Board, general meetings or separate meetings of the holders of any class of shares or of debentures of the Company or otherwise in connection with the discharge of their duties. Documentary evidence of expenses incurred should
be submitted to my office for approval. 
 Shareholding, dealing and compliance 

The 2,500 Prudential qualification shares you purchased within your first year of appointment must be retained during the tenure of your office. 

  
 57 

 The Board has also set a shareholding guideline for Non-executive Directors equivalent in value to the basic annual fee.
This shareholding should be acquired within a three-year period of the appointment becoming effective, or from the date of the introduction of the policy if earlier. 

During your term in office you are subject to Prudential’s Share Dealing Rules, full particulars of which can be found in the Board Reading Room on your iPad. The
rules incorporate all relevant obligations arising from the Company’s listing in HK and the UK, as well as other relevant legislation. These are updated as required to reflect changes in legislation and regulations, and will provide you
with the necessary guidance on the steps you need to take and other considerations relating to share dealings. 
 If you have any questions on this please consult with
Group Secretariat. 
 Conflicts of interests, independence and disclosure obligations 

It is accepted and acknowledged that you have business interests other than those of the Company and we have discussed these and agreed that no conflicts of interest
currently exist (other than those authorised by the Board as part of the appointment process). In the event that you become aware of any future potential conflicts of interest, please disclose these to me and the Company Secretary as soon as
apparent and also prior to accepting appointments. In particular we would not wish our Directors to serve on the Boards of financial services competitors. 
 The Board
of the Company has determined that you are independent according to the provisions of the UK Corporate Governance Code and the Hong Kong Listing Rules, supported by your declaration of independence, and you will be identified as such in the annual
report and other documentation. If you are a member of the Audit Committee, you have also confirmed your independence in respect of the Securities and Exchange Act of 1934 as it applies to members of an audit committee of a Foreign Private Issuer.
If circumstances change, and you believe that your independence may be in doubt, you should discuss this with me as soon as possible. 
 The Company has an obligation
to notify details of other directorships held by its directors during the past five years to various regulators on an annual basis, together with non-statutory offices. Any changes in your external appointments, including non-statutory offices,
should be notified to the Company Secretary on an ongoing basis. In particular, any changes in your directorships of other quoted companies worldwide need to be notified promptly, preferably the next business day, as the Company is required to
announce this to various stock exchanges. 
 Wrongdoing 
 You will immediately
report to the Board your own wrongdoing or the wrongdoing or proposed wrongdoing of any employee or Director of which you become aware. 

  
 58 

 Termination of appointment 
 The
appointment may be terminated by and at the discretion of either party upon six months’ written notice. On termination of your appointment you shall resign from your office as director of the Company and of any offices you hold in any of the
Company’s group companies. Upon termination you will not be entitled to any compensation, other than accrued pro-rata fees, and you shall also cease to be a member of any Committee of the Board. All records, documents, accounts, letters and
papers of every description (including in particular Board and Committee agendas, minutes and papers) within your possession or control relating to the affairs and business of the Group are and will remain the property of the Company, and shall be
returned to the Company forthwith on termination. 
 Notwithstanding the above, your appointment may be terminated with immediate effect if you: 

 

	(a)	commit a material breach of your obligations under this letter; or 

  

	(b)	commit any serious or repeated breach or non-observance of your obligations to the Company (which include an obligation not to breach your duties to the Company, whether statutory, fiduciary or common-law); or

  

	(c)	are guilty of any fraud or dishonesty or acted in a manner which, in the opinion of the Company acting reasonably, brings or is likely to bring you or the Company into disrepute or is materially adverse to the interests
of the Company; or 

  

	(d)	are convicted of any arrestable criminal offence other than an offence under road traffic legislation in the UK or elsewhere for which a fine or non-custodial penalty is imposed; or 

 

	(e)	are declared bankrupt or have made an arrangement with or for the benefit of your creditors; or 

  

	(f)	are disqualified from acting as a director; 

  

	(g)	cease to hold PRA Approved Person status ; or 

  

	(h)	do not comply with the Group Anti-Bribery and Corruption Policy. 

 Confidentiality 

During your appointment you will have access to confidential information regarding the business and financial affairs of the Company and those of its subsidiaries,
undertakings and affiliates. You must not, either during your appointment or afterwards, disclose to anyone or otherwise make use of this confidential information, except in the proper performance of your duties or as may be required by law or by
any competent regulatory body. This does not apply, however, to any information already in the public domain. 

  
 59 

 Your attention is also drawn to the requirements under both legislation and regulation as to the disclosure of price
sensitive information. Consequently you should avoid making any statements that might risk a breach of these requirements without prior clearance from me or the Company Secretary. 

Data Protection 
 By signing this letter, you consent to the Company holding and
processing information about you for legal, personnel, administrative and management purposes and in particular to the processing of any sensitive personal data (as defined in the Data Protection Act 1998) including, as appropriate: 

 

	(a)	your racial or ethnic origin or religious or similar beliefs in order to monitor compliance with equal opportunities legislation; or 

 

	(b)	information relating to any criminal proceedings in which you have been involved for insurance purposes and in order to comply with legal requirements and obligations to third parties. 

You consent to the Company making such information available to any of its group companies, those who provide products or services to the Company (such as advisers and
payroll administrators), regulatory authorities, potential or future employers, governmental or quasi-governmental organisations and potential purchasers of the Company. 

You also consent to the transfer of such information to the Company’s business contacts outside the European Economic Area in order to further its business
interests. 
 Induction 
 Following your appointment, the Company provided an
induction programme which included meetings with senior management and the Company’s auditor and focussed on areas of specific interest to you. As part of your induction and during your term in office you received briefings on your duties as a
director generally and as a director of a company listed in the UK and HK. You also subsequently received a briefing on your obligations as a PRA Approved Person. 

Board evaluation 
 The performance of individual Directors and the whole Board
and its Committees is evaluated annually. If, in the interim, there are any matters which cause you concern about your role you should discuss them with me as soon as is appropriate. 

  
 60 

 Professional development 
 As a
Director you are invited to appropriate educational and/or professional development programmes from time to time. The Company Secretary will consult each director annually to ascertain their specific professional development needs. 

Directors’ and officers’ protection 
 The Company has directors’
and officers’ liability insurance and it is intended to maintain such cover for the full term of your appointment. A brief summary of the cover can be found in Prudential’s Guidance Notes for Directors, which is updated on a regular basis.

 The Company has also provided you with indemnity cover for directors’ and officers’ liability within the limitations imposed by law. In addition, the
Company will provide you with a limited indemnity for certain personal liabilities you may suffer in the course of your appointment, subject again to applicable statutory and other limitations, pursuant to the Company’s constitutional documents
or otherwise. 
 The Board has also resolved to have a discretionary payments policy (subject to regular review), the existence of which Directors (executive and
non-executive) and certain employees or members of the Prudential Group may rely on, to protect them from personal liability arising out of the bona fide performance of their duties on behalf of the Group. 

Independent professional advice 
 Occasions may arise when you consider that you
need professional advice in the furtherance of your duties as a Director, and it may be appropriate for you to seek advice from independent advisers at the Company’s expense. This would normally be arranged through the Company Secretary. The
Company will reimburse the full cost of expenditure incurred in accordance with the policy. Details of the agreed procedure under which Directors may obtain such independent advice can be found in the Prudential Guidance Notes for Directors. 

Governing law and jurisdiction 
 This letter and any non-contractual obligations
arising out of or in connection with it shall be governed by English law. The English courts have exclusive jurisdiction to settle any dispute arising in respect of it. 

Yours sincerely 
 /s/ Paul Manduca 

Paul Manduca 
 Chairman 

Prudential plc 

  
 61 

 Acknowledgement: 
  

	1.	By signing this letter, I agree to its terms. 

  

	2.	I acknowledge that this appointment letter does not constitute a contract of employment. 

  

	3.	I confirm that by having accepted this appointment, I am able to allocate sufficient time to meet the demands of the role. 

Signed: /s/ Alice Schroeder 
 Dated: 27.02.2014 

  
 62 

 Alice Schroeder 

Schedule 1 – Committee memberships as at 1 July 2016 
  

	 	•	 	Audit Committee 

 Schedule 2 – time commitment and fees as at 1 July 2016 

 

									
	 	  	 	  	Number
of regular
scheduled
meetings	  	Approximate
time commitment	  	Fees
per
annum
	 Board
	  		  	8	  	31 days	  	£95,000
	 Audit Committee
	  	Chairman Member	  	5	  	22.5-27.5 days
 15 days
	  	£75,000
 £27,500

	 Risk Committee
	  	Chairman Member	  	5	  	19-24 days
 7.5 days
	  	£75,000
 £27,500

	 Remuneration Committee
	  	Chairman Member	  	4	  	18-23 days
 5 days
	  	£60,000
 £27,500

	 Nomination Committee
	  	Member	  	2	  	4 days	  	£10,000
	 Senior Independent Director
	  		  		  	10-25 days	  	£50,000

 Note: 
 In addition to the regular scheduled
meetings, the Committees may hold additional shorter meetings as relevant to discuss, for example, periodic financial reports, succession planning and other issues as they arise. 

  
 63 

 Exhibit 4.6 

17 September 2015 
 Dear Adair 

PRUDENTIAL PLC - LETTER OF APPOINTMENT 
 I am delighted to confirm that the
Board of Prudential plc (the ‘Company’) has agreed to appoint you as Non-executive Director and member of the Audit Committee with effect from 15 September 2015. 

I am now writing to set out the terms of your appointment. It is agreed that this is a contract for services subject to the Company’s Articles of Association as
amended from time to time and does not constitute a contract of employment. 
 Appointment 

Your appointment is subject to election by shareholders at the AGM in 2016 and to receipt of all necessary legal and regulatory approvals. Continuation of your
appointment will be contingent on satisfactory performance, re-election at forthcoming AGMs and any statutory provisions relating to the removal of directors. Non-executive Directors are appointed on the understanding that they serve an initial term
of three years and, subject to review by the Nomination Committee, a second term of three years, both subject to annual election at the AGM. After six years of service, Non-executive Directors may be appointed for a further year, up to a maximum of
three years, subject to an annual review by the Nomination Committee. Good governance does not support the practice of serving longer than nine years on the Board as a Non-executive Director. 

If you are not confirmed or re-elected as a director by shareholders, or you are retired from office under the Company’s Articles of Association, your appointment
shall terminate automatically with immediate effect. 
 Participation in Committees 

Non-executive members of the Board are invited to serve on Committees of the Board, as determined by the Board from time to time. The principal Committees are Audit,
Risk, Remuneration and Nomination. The Schedule to this letter, as amended from time to time, lists the Committees of which you are a member. 
 Role 

Non-executive Directors have the same general legal responsibilities to the Company as any other Director. The Board as a whole is collectively responsible for the
success of the Company. The Board: 

  
 64 

	•	 	Provides entrepreneurial leadership of the Company within a framework of prudent and effective controls which enable risk to be assessed and managed; 

 

	•	 	Sets the Company’s strategic aims, ensures that the necessary financial, human and other resources are in place for the Company to meet its objectives, and reviews management performance; and 

 

	•	 	Sets the Company’s values and standards and ensures that its obligations to its shareholders and others are understood and met. 

Directors of any company must take decisions objectively in the interests of that company. As a director, you owe a fiduciary duty to the Company, which includes an
obligation not to do anything that might bring it into disrepute. A summary of responsibilities of Directors as applicable to the Company under current legislation will be provided to you. 

In addition to these general requirements of all Directors, the role of the Non-executive Director has the following key elements: 

 

	 	•	 	Strategy. Non-executive Directors should constructively challenge and help develop proposals on strategy. 

  

	 	•	 	Performance. Non-executive Directors should scrutinise the performance of management in meeting agreed goals and objectives and monitor the reporting of performance. This is achieved both at the Board and on a
more individual level through the Remuneration Committee. 

  

	 	•	 	Risk. Non-executive Directors should satisfy themselves of the integrity of financial information and that financial controls and systems of risk management are robust and defensible. This is achieved by
escalating key issues to the Board either directly or via the Audit Committee. The Group Risk Committee also has an important role in this context. 

  

	 	•	 	People. Non-executive Directors have a prime role in appointing, and where necessary removing, Executive Directors and in succession planning. In addition, they are responsible for determining appropriate levels
of remuneration for Executive Directors. This business is mainly conducted via the Nomination and Remuneration Committees. Non-executive Directors also have a prime role in upholding high standards of integrity and probity and in supporting the
other directors in instilling the appropriate culture, values and behaviours in the boardroom and beyond. 

 In this role, you are a PRA Approved Person,
holding a Non-executive Director controlled function (CF2) in respect of The Prudential Assurance Company Limited (“PAC”). As an Approved Person, you must: 
  

	 	•	 	comply with the Statements of Principle and Code of Practice for Approved Persons (“APER”) set out in the APER section of the PRA Handbook; and 

 

	 	•	 	meet on an ongoing basis the fit and proper person test for Approved Persons (which covers honesty, integrity and reputation; competence and capability; and financial soundness). 

  
 65 

 Group Compliance will provide you with guidance on the obligations of Approved Persons and how these apply to your role as a
Controlled Function holder in respect of PAC. 
 Time Commitment and fees 

Time commitment will depend on the Committees on which you serve and may change over time, depending on the issues faced by the business and your time in the role. The
Schedule to this letter provides the current time expectations for Board and Committee membership. The Schedule is reviewed on an annual basis and may be amended from time to time by the Company. 

Whilst we acknowledge that you have other commitments which may mean you will not be able to attend all meetings of the Board and relevant Committees, you have confirmed
by accepting this appointment that you are able to allocate sufficient time to the Company’s affairs to meet the demands of the role. You must discuss any additional commitments that might impact on the time you are able to devote to your role
as a Non-executive Director of the Company with me prior to accepting. 
 Non-executive Directors’ fees are subject to annual review by the Board, and will be in
accordance with the policy approved by shareholders from time to time, as required under the Companies Act 2006 (the “Approved Policy”). Fees accrue on a daily basis and are payable quarterly in arrears. The fees currently payable for
Board membership and the additional fees payable for other Committee memberships are set out in the Schedule to this letter, as amended from time to time. All fees are payable net of any tax and National Insurance contributions, where the Company is
required to deduct these. 
 As a Non-executive Director you are not entitled to participate in any of the Group’s executive remuneration programmes or pension
arrangements. 
 Directors are entitled to claim for business related expenses properly incurred by them in connection with their attendance at meetings of the Board
or Committees of the Board, general meetings or separate meetings of the holders of any class of shares or of debentures of the Company or otherwise in connection with the discharge of their duties. Documentary evidence of expenses incurred should
be submitted to my office for approval. 
 Shareholding, dealing and compliance 

You are required to hold 2,500 qualification shares in Prudential plc, which must be purchased within your first year of appointment must be retained during the tenure of
your office. 
 The Board has also set a shareholding guideline for Non-executive Directors equivalent in value to the basic annual fee. This shareholding should be
acquired within a three-year period of the appointment becoming effective. 

  
 66 

 During your term in office you are subject to Prudential’s Share Dealing Rules, full particulars of which can be found
in the Board Reading Room on your iPad. The rules incorporate all relevant obligations arising from the Company’s listing in HK and the UK, as well as other relevant legislation. These are updated as required to reflect changes in
legislation and regulations, and will provide you with the necessary guidance on the steps you need to take and other considerations relating to share dealings. 
 If
you have any questions on this please consult with Group Secretariat. 
 Conflicts of interests, independence and disclosure obligations 

It is accepted and acknowledged that you have business interests other than those of the Company and we have discussed these and agreed that no conflicts of interest
currently exist (other than those authorised by the Board as part of the appointment process). In the event that you become aware of any future potential conflicts of interest, please disclose these to me and the Company Secretary as soon as
apparent and also prior to accepting appointments. In particular we would not wish our Directors to serve on the Boards of financial services competitors. 
 The Board
of the Company has determined that you are independent according to the provisions of the UK Corporate Governance Code and the Hong Kong Listing Rules, supported by your declaration of independence, and you will be identified as such in the annual
report and other documentation. If you are a member of the Audit Committee, you have also confirmed your independence in respect of the Securities and Exchange Act of 1934 as it applies to members of an audit committee of a Foreign Private Issuer.
If circumstances change, and you believe that your independence may be in doubt, you should discuss this with me as soon as possible. 
 The Company has an obligation
to notify details of other directorships held by its directors during the past five years to various regulators on an annual basis, together with non-statutory offices held in a professional capacity. Any changes in your external appointments,
including non-statutory offices, should be notified to the Company Secretary on an ongoing basis. In particular, any changes in your directorships of other quoted companies worldwide need to be notified promptly, preferably the next business day, as
the Company is required to announce this to various stock exchanges. 
 Wrongdoing 

You will immediately report to the Board your own wrongdoing or the wrongdoing or proposed wrongdoing of any employee or Director of which you become aware. 

Termination of appointment 
 The appointment may be terminated by and at the
discretion of either party upon six months’ written notice. On termination of your appointment you shall resign from your office as director of the Company and of any offices you hold in any of the Company’s group companies. Upon
termination you will not be entitled to any compensation, other than accrued pro-rata fees, and you shall also cease to be a member of any Committee of the Board. All records, documents, accounts, letters and papers of every description (including
in 

  
 67 

 
particular Board and Committee agendas, minutes and papers) within your possession or control relating to the affairs and business of the Group are and will remain the property of the Company,
and shall be returned to the Company forthwith on termination. 
 Notwithstanding the above, your appointment may be terminated with immediate effect if you: 

 

	(a)	commit a material breach of your obligations under this letter; or 

  

	(b)	commit any serious or repeated breach or non-observance of your obligations to the Company (which include an obligation not to breach your duties to the Company, whether statutory, fiduciary or common-law); or

  

	(c)	are guilty of any fraud or dishonesty or acted in a manner which, in the opinion of the Company acting reasonably, brings or is likely to bring you or the Company into disrepute or is materially adverse to the interests
of the Company; or 

  

	(d)	are convicted of any arrestable criminal offence other than an offence under road traffic legislation in the UK or elsewhere for which a fine or non-custodial penalty is imposed; or 

 

	(e)	are declared bankrupt or have made an arrangement with or for the benefit of your creditors; or 

  

	(f)	are disqualified from acting as a director; or 

  

	(g)	cease to hold PRA Approved Person status ; or 

  

	(h)	do not comply with the Group Anti-Bribery and Corruption Policy. 

 Confidentiality 

During your appointment you will have access to confidential information regarding the business and financial affairs of the Company and those of its subsidiaries,
undertakings and affiliates. You must not, either during your appointment or afterwards, disclose to anyone or otherwise make use of this confidential information, except in the proper performance of your duties or as may be required by law or by
any competent regulatory body. This does not apply, however, to any information already in the public domain. 
 Your attention is also drawn to the requirements under
both legislation and regulation as to the disclosure of price sensitive information. Consequently you should avoid making any statements that might risk a breach of these requirements without prior clearance from me or the Company Secretary. 

  
 68 

 Data Protection 
 By signing this
letter, you consent to the Company holding and processing information about you for legal, personnel, administrative and management purposes and in particular to the processing of any sensitive personal data (as defined in the Data Protection Act
1998) including, as appropriate: 
  

	(a)	your racial or ethnic origin or religious or similar beliefs in order to monitor compliance with equal opportunities legislation; or 

 

	(b)	information relating to any criminal proceedings in which you have been involved for insurance purposes and in order to comply with legal requirements and obligations to third parties. 

You consent to the Company making such information available to any of its group companies, those who provide products or services to the Company (such as advisers and
payroll administrators), regulatory authorities, potential or future employers, governmental or quasi-governmental organisations and potential purchasers of the Company. 

You also consent to the transfer of such information to the Company’s business contacts outside the European Economic Area in order to further its business
interests. 
 Induction 
 Following your appointment, the Company will provide
an induction programme which will include meetings with senior management and the Company’s auditor and will focus on areas of specific interest to you. As part of your induction you will receive a briefing on your duties as a director
generally and as a director of a company listed in the UK and HK. You will also receive a briefing on your obligations as a PRA Approved Person. 
 Board evaluation

 The performance of individual Directors and the whole Board and its Committees is evaluated annually. If, in the interim, there are any matters which cause you
concern about your role you should discuss them with me as soon as is appropriate. 
 Professional development 

As a Director you are invited to appropriate educational and/or professional development programmes from time to time. The Company Secretary will consult each director
annually to ascertain their specific professional development needs. The Company will also provide you with relevant briefings affecting your duties as a director. 

  
 69 

 Directors’ and officers’ protection 

The Company has directors’ and officers’ liability insurance and it is intended to maintain such cover for the full term of your appointment. A brief summary of
the cover can be found in Prudential’s Guidance Materials for Directors, which are available on iPad. 
 The Company has also provided you with indemnity cover
for directors’ and officers’ liability within the limitations imposed by law. In addition, the Company will provide you with a limited indemnity for certain personal liabilities you may suffer in the course of your appointment, subject
again to applicable statutory and other limitations, pursuant to the Company’s constitutional documents or otherwise. 
 In addition, the Board has resolved to
have a discretionary payments policy (subject to regular review), the existence of which Directors (executive and non-executive) and certain employees or members of the Prudential Group may rely on, to protect them from personal liability arising
out of the bona fide performance of their duties on behalf of the Group. 
 Independent professional advice 

Occasions may arise when you consider that you need professional advice in the furtherance of your duties as a Director, and it may be appropriate for you to seek advice
from independent advisers at the Company’s expense. This would normally be arranged through the Company Secretary. The Company will reimburse the full cost of expenditure incurred in accordance with the policy. Details of the agreed procedure
under which Directors may obtain such independent advice can be found in the Prudential Guidance Materials for Directors. 
 Governing law and jurisdiction 

This letter and any non-contractual obligations arising out of or in connection with it shall be governed by English law. The English courts have exclusive jurisdiction
to settle any dispute arising in respect of it. 
 Yours sincerely 
 /s/ Paul
Manduca 
 Paul Manduca 
 Chairman 

Prudential plc 

  
 70 

 Acknowledgement: 
  

	1.	By signing this letter, I agree to its terms. 

  

	2.	I acknowledge that this appointment letter does not constitute a contract of employment. 

  

	3.	I confirm that by having accepted this appointment, I am able to allocate sufficient time to meet the demands of the role. 

Signed: /s/ Adair Turner 
 Dated: September 2015 

  
 71 

 Lord Turner 
 Schedule
1 – Committee memberships as at 1 July 2016 
  

	 	•	 	Risk Committee 

 Schedule 2 – time commitment and fees as at 1 July 2016 

 

									
	 	  	 	  	Number
of regular
scheduled
meetings	  	Approximate time
commitment	  	Fees
per
annum
	 Board
	  		  	8	  	31 days	  	£95,000
	 Audit Committee
	  	Chairman Member	  	5	  	22.5–27.5 days
 15 days
	  	£75,000
 £27,500

	 Risk Committee
	  	Chairman Member	  	5	  	19-24 days
 7.5 days
	  	£75,000
 £27,500

	 Remuneration Committee
	  	Chairman Member	  	4	  	18-23 days
 5 days
	  	£60,000
 £27,500

	 Nomination Committee
	  	Member	  	2	  	4 days	  	£10,000
	 Senior Independent Director
	  		  		  	10-25 days	  	£50,000

 Note: 
 In addition to the regular scheduled
meetings, the Committees may hold additional shorter meetings as relevant to discuss, for example, periodic financial reports, succession planning and other issues as they arise. 

  
 72

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00268-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00268-of-00352.parquet"}]]